Clinical

EH
nested case-control



tertiary_ referral centre
EC

molecular
dXA
FM
exercise cardiovascular health
HF
devices_ in_heart_ failure
Liver disease
Renal artery stenosis
hospital_ mortality
Retrospective cohort
acute_ surgery heart transplant recipients
heart_ failure Latin America


Retrospective cohort

HF
90-day_ mortality





doctors
Heart
Nutrition_ in_heart_ failure

heart_ failure

Cross-sectional
INTERVENtions
unilateral
Heart_ failure


clin
trans


Intermediate_frailty

CHF
dodson



HF
rates CHF
Heart_puissance

air pollution heart_ failure
extracorporeal support
cardiovascular disease
Heart_ failure
hemostasis
ischemic conditioning heart_ failure
Heart rate_variable






Sham-operation_animal
retrospective descriptive

HF
benefits cardiovascular
Cell Anand


doxorubicin
doctors transfusions
Heart_ failure bisphosphonates
diuretic_utilisation heart_ failure
caspase heart_ failure
cox proportional_ hazards
right heart_ failure pulmonary hypertension
HF
hypertension


cronbach

patient_ safety conditions

implanted_ monitoring devices

HR_modulates_ Ea
periprocedural strokes
RAS atherosclerosis
frailty_ in_heart_ failure communauté
PSSS
microRNAs heart_ failure disease management

cox regression
Cardiology implantation heart_ failure
management_de_ heart_ failure ejection_fraction
Median_ age
inpatient_ medical conditions
Jehovah_s_ Witness anemia
cardiology university_hospital
HFpEF
HF
autonomic balance
impact_de_frailty HF
hospital_de_ worsening_ heart_ failure

Heart_ failure cognitive impairment mortality
LV_ fibrosis
median_ follow-up
competitive collateral
CO
heart_ failure hospitalization cardiovascular death
cognitive_fonctionnel
vasopressin congestive heart_ failure
cardiac transplantation
Mitral_ stenosis_ reversed medical treatment heart_ failure
pde2 HF

propensity

black

metric_ choice readmission_ metrics

readmission metric
physician_ volume hospital physician_specialty
Residual confounding
Median_ follow-up
Arrhythmia-related costs
Medication

sts_HM
réseau_meta-analysis
surgical_ tactiques circulatory_ arrest

mortality
ejection_fraction bNP

Chronic HF
MR MS
hpEF
Cardiac_amyloidosis
Pigs antiarrhythmic medication
Robot-assisted_training heart_ failure

CHF

Heart rate arterial_tension
therapy beta_blockade
hgb hgb baseline HRQoL
cardiac_ and_ inflammatory biomarkers
systolique_ dysfunction
preserved ejectionfraction
HF cardiovascular hospitalization
biomarkers chronic_heart_ failure
heart_ failure emergency department
VO2max

mAIN oUTCOME_measure TUG
HR HF
biomarkers
ESRD




abnormal cardiac



risk
Heart_ failure ventricular ejectionfraction
quality_of_ life
cox proportional_ hazards
Tolvaptan vasopressin receptor
Epidemiology chronic_heart_ failure bisoprolol
spironolactone systolic_ heart_ failure
Heart_ failure HF mortality
Functional MS degenerative MR
eRK molecular_ scaffolds heart_pathologie
heart_ failureHF therapy
aortic_tension_ curve
Cardiac
Nights hospital coprimary outcome
Trastuzumab-related_ cardiotoxicity breast cancer
Heart_ failure public_ health
physician_continuity discharge
Postoperative_ normalization albumin
pathophysiological
implantation
patients_contre_la_heart_ failure
gross_ income health per capita
AHA ESC

clinician expertise HF
stand-alone_Diagnos devices HF
cPGs
enrollment

therapy


ms
cox proportional_ hazards
dialysis implantation
psychometric_ testing Self-Care_de_ Heart_ Failure
cox proportional_ hazard
endothelial_fréquence flow-mediated dilatation
acute_ kidney injury
Pharmacological treatment acute_heart_ failure
multiorgan_ failure sepsis
Nordic_ walking

survival Seattle Heart_ Failure Model
Hemodynamic_ phenotype failing Fontan
MS surgery echocardiography
Coronary_angiography


off-pump_sternal_ sparing HeartMate_ II exchange

QRs

nursing
implantation


deficits

gLS
MS

anaerobic_ threshold heart_ failure
renin-angiotensin-aldosterone
CHF unilateral renal DNx cardiac_ autonomic balance
skeletal_ muscle_ abnormalities Fontan_ circulation
acute_heart_ failure
chronic_ kidney diseaseCKD
Mitral_regurgitation HF
progressive hypertension kidney_ failure

hospital_for_heart_ failure discharge
systolic HF

mAIN_oUTCOME
abnormal HR_ variability sudden cardiac_ death
toxicity
medication resting_hemodynamics
Physician
indices postsystolic
aac cardiac_ hypertrophy
patient_ satisfaction
économiques coût
ICU_ mortality
Nurses patients
cRT dialysis-dependent patients
CHF

HF
hypoalbuminemia
angiotensin receptor_ neprilysin inhibitor heart_ failure
cardiac_sodium_ current systolic_ human heart_ failure
diastolic dysfunction peripheral artery_ disease
immunohistochemistry electron microscopy
idiopathic dilated_ cardiomyopathy
ischemic_ cardiomyopathy male sex mortality
hypertensive LV dysfunction MR MS
HF chromatin_ hyperacetilation
physicians HF
Race efficacy spironolactone
sinus rhythm AF
ingenuity
heart_ failure cardiac rehabilitation
cd HF
Myocardial infarction Wistar rats

anemia
acute_heart_ failure
public reporting
care_management telehealth medicare

algorithms post-LVAD AI
Population-based
Rhythm- and rate-control

TAC
MS mva
cRF
Mediterranean DASh
social_ support
diabetes e-cFUs
Risk hospitalization heart_ failure
Cardiac-resynchronization_therapy_ in_heart_ failure QRS
hospital_ readmission_reduction_program congestive_heart_ failure
Blacks VO2
odds ratios hospital_ clustering
hff HFpf
nitroxyl
physician continuity urgent_ readmission_de_discharge patients heart_ failure
Heart_block pulmonary artery_ snared BiVP
feasibility
inflammation metabolism heart
cardiovascular events
change LVET follow-up
bioinformatic
CAD cause_de_ systolic_ HF
diuretic HF
surgical MS
af patients echocardiographic

congenital_ heart_ lesions
PVf PB amplitude
BB therapy
Cardiac_fonctionnel pressure-volume_conductance catheter
MS HF surgical indication MS
beta-blockers
safety_ end point
holosystolique_ murmur
eligibility heart implantation left ventricular_assist device
ventricular
remodelling HF haemodynamic neuronal stressors
subclinical_atherosclerosis
Exercise_ intolerance chronic_heart_ failure
preoperative hypoalbuminemia lVAD
coronary_ disease heart_ failure

deficit_ index biological_ phenotype mortality
atrial_ fibrillation_AF heart_ failure
cachexia ventricle heart_ failure complicity
signalling_pathways maladaptive cardiac remodelling
eCGs electrocardiographers
AVd VVD free wall

ESRD outpatients HF
branch block_electrical_activation_sequence
hHF dp-4 inhibitors
ECCT advanced_heart_ failure therapy
CV death_non-fatal stroke hospitalisation heart_ failure
Protective_effects éet endothelial_ function
heart_ transplant
Ffffffffffffff_fffff figure_ffff
periprocedural complications dialysis
precipitation hff
multihospital adoption_de_heart_ failure
Southeastern Minnesota HF
Cardiac_caxiaCC
Frailty HF
proteome_de_ HDL particles shotgun LC-MS
Fatal_nonfatal
preoperative_ clinical
miRNAs cardiac
mortality iCD-HF
transfusion
septal defects surgical
discharge medication
heart_ failure_de_capitaux
bromodomain proteins
mortality
bt DT implantation
hypotension interrupt
pharmaceutically_assisted
incident HF
biomarkers HF
Peak VO2

économique

trastuzumab-related CHF
implants

hospitals
financiers

HF hospital_admissions ventricular_assist device
Coronary_ artery disease CAD systolic_heart_ failureHF
Heart_ failure rheumatoid_arthritis TNF antagonist
Renal artery_ stenosis RAS peripheral_ arterial
Wilcoxon
ventricular_assist device right ventricular_support
psoriasis atherosclerosis incident_ cardiovascular events Rotterdam
hospitals

eplerenone
Orthotopic_heart_ transplantation oHT
Right atrial_Myxoma pulmonary embolism right heart_ failure
Unilateral_ renal_ denervation autonomic_ balance conscious rabbits
Myxomas pulmonary arterial_ vasculature
high-risk patient heart_ failure ejection_fraction
mr-25 transcription_factor Hand2 heart_ failure
HF
coronary_ heart disease stroke heart_ failure
VEGF_ inhibition b cardiac remodeling
β-blockerBB sST2
readmissions heart_ failure
MLHF
Pediatric heart_ failure HF morbidity mortality
resistin ejection_fraction
Patients heart_ failure medication
ECCT cardiac transplantation
cPET_guiding_ exercise_ rehabilitation CHF

Heart_ failure HF cardiovascular_hospitalization
malfunctioning HeartMate_ II LVADs

Renal DNx circulation_ plasma CHF-INV rabbits
EH hpEF
dysfunction pump_ failure driveline_ injury

hHF saxagliptin sitagliptin
caspase paced_Myocardium
ischemic_inflammatory_ abdominal
renal_ dysfunction long-term_transplant_ morbidity
MedLine EMBAse cINAHL
ACR CMS
HF
anemia
survival_ to_hospital_discharge
Heart_puissance_de_corruption
HDL-bound malondialdehyde HDL-induce production EC
HF
NP
trastuzumab
implantation
hCT germline_DNA genotype


CAD

cPCs VO2
bottleneck_ stent chronic_ myocardial_ischemia heart_ failure pigs
Gastrointestinal_ bleeding ventricular_assist devices cardiac nurse
LV filling_puissance HF
coronary artery diseaseCAD
hospital_discharge patients_contre_heart_ failure réseau
Soluble_ ST2 in ambulatory patients_with_ heart_ failure
Cardiac Mammalian_ enabled mena heart_ failure mice
Titin_hyphosphorylation myocardial DD
echocardiograms
lVAS implantation destination_therapy
apoptosis canine_model_de_ chronic_ heart_ failure tachycardia

RAS- β-blocker_uptitration HFpEF
Framingham Heart_ Study HF EF
aCP clinical_prudentience
diuretics
ED intubations congestive_ heart_ failure
eAST rhythm_control therapy cardiovascular complications AF
Cardiac_ hypertrophy énergétique
HF
Nicorandil doxorubicin
Frailty_de_fréquence_fréquence heart_ failure aging
Heart
DEGs osprey networks
HRQoL hgb
NOc
AF-free probability catheter ablation maintenance sinus rhythm
paediatric cardiac transplants
inpatient records HF
iCD-HF
pneumonia conditions
cardiovascular
aRIC HF
implantation cRT
therapy


deficit
Medicare post-acute_care_transfer_policy

ED CHF
vegetables nuts grain intake

groupes_ validity
iron
ventricular_contractile_ reserve pulmonary hypertension
QT_ intervals SDQT
emergency_ cardiac_ catheterization
implantation_des_chron_heart_ failure implantation_de_la_tension_ lipoprotein
resistin acute anthracycline-induced cardiotoxicity
BAT sympathetic_ outflow parasympathetic activity

acute_ autonomic_ nervous_system_ modulation QTV HF
Heart_aortic_ blood_ flow doxorubicin
RVPO BiVP RS synchrony CS
cardiac_resynchronization_therapy dialysis-dependent patients heart_ failure
cardiovascular_ death HF hospitalisation btes
skeletal_ muscle_ mass VO2
ventricular-arterial coupling SV
double-blind active
Myocardial_pde2 expression HF
diastolic_ failure cardiomyopathic restriction
hospitalisations readmissions mortality
psychosocial factors
autonomic_ nervous_system_ activity QTV
pump_changes pump thrombosis hemolysis
atrial_ fibrillation pacemaker
body_ index cRF treadmill
human_méocardial_ tissue pKA
electronic databases World_ Health Organization HF
implantions

cardiac_stress β-AR
ethics_ Rounds
PSSS social_support btes barriers
bisoprolol
Frailty elderly adverse
ED visits CHF intubation
physician_continuity conditions
Medicare fee-for-service
clinical therapeutic

SD diet_adherenceSD

parallel-group cohort
renal DNx cardiac_ autonomic balance CHF sympathetic tone
anemia patients_contre_heart_ disease clinical_practiline American College_of_ Physicians
end-stage renal disease outpatients systolic_ heart_ failure
parasympathetic_ neurotransmission acetylcholinesterase inhibition
heart_reduction ivabradine left ventricle heart_ failure
Heart_ Failure Pathophysiology Medical Treatment_ Guidelines Nursing Management
medical_management_of_heart_ failure Canadian_ Cardiovascular_ Society
biomarkers neurohormonal stimulation inflammation endothelial dysfunction
echocardiographic reverse remodeling cardiac_resynchronization
Neurohormonal abnormalities pathophysiology congestive_heart_ failureCHf
miRNAs
RV_ dysfunction
morbidity HF
cardiopulmonary_réquence
l-type_ca2_ currents Rad congestive_ heart_ failure
radiological HF
ventricle RV cardiac
Jehovah_s_ Witness sickle_cell_ disease anemia
mri scanner heart
congestive_heart_ failureCHf

chromatin_subproteome mouse heart
muscle-wasting_ syndrome acquired_heart_ failure Fontan
Mediterranean DASh_diet_ scores mortality women heart_ failure Womens_Health Initiative
LVEF long-term_ mortality
ctnt NT-probNP HF
inhospital_ mortality bNP
Health Buddy_program ED hospitalized
resistin anthracycline-treated breast cancer cardiotoxicity
Health Buddy_program content-driven telehealth_system care management
Mortality aCS
therapeutic
dobutamine furosemide oxygen
cPCs diabetes
fréquence
Patients consultation abdominal
complication

futility
acute RV_ failure left ventricular_ dysfunction
ventricular ejection acute_ heart_ failure precapillary_ pulmonary hypertension
aortic valve insufficiency ventricular implantation
ejection_fraction cardiac_ resynchronization_therapy mild_heart_ failure
biventricular_pacing left_ heart_ twist porcine_model_de_ right_ heart_ failure
myocardial_ diastolic_ dysfunction DD collagen_deposition titin modification
Stress doppler echocardiography pulmonary hypertension
septal wall_ CS avd free wall_ CS VVD
inhibition protein_ kinase soluble guanylate_ cyclase contractile
implantation circulatory_assist device
systolic_de_ diastolic_metral leaflet
circulation_progenitor_cells heart_ failure
mg myocardial
cs regression
pulmonary artery

HR_reduction beta_blockers exercise_capacitation hFrEF
LV echocardiography ablation
cPCs functional_ capacity heart_ failureHF
pressure_ ulcers surgical
echocardiographic invasive_hemodynamic
CHF atrial_ explants c-Kit_cells sham explants
bundle-branch_blockLBBBLBBB
cardiac_ Mena deletion cardiac_ dysfunction hypertrophy
PD refractory end-stage_congestive_heart_ failureCHf

économique
trastuzumab cardiac

HF valve plasty MS mVA
multivariable_multivariable_regressions insurance_status comorbidities

figure
Human resistin chemotherapy_induced heart_ failure humanized male mice breast cancer


therapeutic
Nursing-sensitive outcome_change scores hospitalized_ older adults heart_ failure
temps_up_go
black_race
transcatheter
chelation heart_ iron
social support barriers
Chinese_ herbal medicine dilated_ cardiomyopathy heart_ failure
implantable implantable implantable cardioverter-de_defibrillator_de_activation
proteines Western blot DNA_ fragmentation TUNEL autopsy
Heart_puissance
HFPEF dietary_sodium restriction ventricular vascular stiffness
EH cardiac filling_tensions
electromechanical_delay dyssynchronous_heart_ failure
apoptosis pacing-induced_ dilated_ cardiomyopathy
chronic_heart_ failureCHf sympathetic_ tone autonomic_ imbalance
right atrium_ mass prolapse tricuspid valve stenotic_ physiology
mt
Fontan_fréquence ventricular liver
Western blots monoclonal_antibodies Ser83 phosphorylation HF
cardiac_ catheterization thrombotic_ obstruction right coronary artery
preoperative serum albumin ventricular implantation
magnetically_ Levitated Left Ventricular Assist HF
coût-effective
closure
cardiac nurses
consultations
transfusion_ thresholds
risk_de_heart_ failure
UM/VA-RT
adverse neurological
BETs mouse TAC
Czech Republic
chemical instability nitrite vascular
MADit-cRT
HF
dopamine nesiritide
extracorporeal membrane_ oxygenation infarction_related_ refractory_ right heart_ failure
California office_de_ State_wide_ Health_planning_de_ Development Patient_discharge
LV_dilatation
HRQoL
inotropic
echocardiography shunt implantation
énergie_ metabolism hypertrophied heart
temps-varying Seattle Heart_ Failure
anticoagulation therapy_de_ underlying heart_control
ED physicians suburban hospitals New Jersey
pathophysiology HF medical management
Paco2 cerebral_ blood_ flow carotid bodies
mechanical_ cardiac_ support renale
heart_puissance protein_ kinase
ECmo VAD
cox regression cardiovascular events psoriasis
PAD ankle-brachial index

HR ivabradine TAC
cp recommendations HF
mortality cancers health-care budget
NT-proBNP circulation HF
patients preserved_synchron_ function therapeutic
HDL-induced_ NO production flow-mediate_dilatation ET
NT-proBNP
aHF

HF
iCD
computing_ readmissions hospital rankings pay-for-performance
Reasons_nontreatment
cox
Exercise intolerance_ intolerance heart_ failure
psoriasis
bNP NT-proBNP
functional MS ring_ annuloplasty ischemic MR LV dilatation
vasopressin_ receptor_ antagonist tolvaptan Japanese heart_ failure
pro-adrenomedullinMR-proADm FFM
interleukin_ receptor_family_ member ST2 beta-blocker therapy
Heart_association
ventricular_assist device extracorporeal membrane_ oxygenation pediatric heart_ failure
Cardiorespiratory_ fitness body_ mass index heart_ failure_ mortality
TUG_test patients advanced COPd CHF cRF
cardiovasculare diabetes mellitus hypertension hyperlipidaemia
isoproterenol cXL-1020 myocytes
HF spontaneous VT beat-to-beat QT
heart_ failure
biventricular_ dysfunction
HF cardiac_ murmurs blood_tension hg
Functional MS
ventricular_assist devices device therapies
renal_ dysfunction
implantation
ventricular_dilatation dysfunction
PB PB HF
implantation anemia patients_with_heart_de_capitence
CF lVAD
social mandate
TREatment hemodynamically_ unstable cPR
cfa
rhythm-control rate-control
Heart_ failure HF debilitating chronic disease demographic

hemoglobin
HF_ epidemiology health service HF

hospital_ length_de_ stay rehospitalization
sudden_ cardiace

administration trastuzumab-related CHF
long-term_ survival
hospitals
biomarker-guided clinical trials
structure_de_juridiques

cardiac_ angiogenesis in vivo coronary_perfusion cardiac_ fibrosis
heart_ failure HF ventricular_ ejection_fractionHFpEF
Circulation_pro-B-type natriure_peptides heart_ failure
Pyridostigmine myocyte collagen_ density surviving left ventricle
ejection_fraction ef collateral_ growth myocardial_perfusion
Heart_ failure hf sympathetic_ activity parasympathetic_control_de_heart
atrial_ fibrillation congestive heart_ failure rhythm-control rate-control
end-stage_heart_ failure implantation long-term ventricular_assist device
ATP XO-mediated ROS mitochondrial_ respiration contractile
adenylyl_ cyclase g-protein coupling
implantable_ cardiac_de_fibrillator
Exercise_ intolerance hff
signaling_pathways pressure-overload-induced heart_ failure
implantation instability heart_ failure ventricular_tachycardia
systolic HF unclear etiology coronary_ angiography
structure SCHFI
energie_ substrate_ metabolism
diabetes mellitus cardiovascular disease
parasympathetic_function therapeutic_alternative HF
HFpEF
surgical_revascularization catheter-based revascularization
HR tNF_ antagonists nbDMARD
incident CVd psoriasis
bNP PAD bNP
Morpholino-based knockdown nucleolin protein expression morphological
clinical_ prediction_ rule CAD systolic HF
population-based Rotterdam
cognitive impairment
race HF
hgb kccq
sonographic implantations gastrointestinal
aCS patients VAD
hospital cardiac_specialty_hospital
haemodynamic pulmonary peripheral abnormalities
ECmo eGFR
HF-related cachexia RV

prediction_ rule
acute HF
Heart_puissance HF
pump-exchange technique redo sternotomy cardiopulmonary_ bypass
HF HF MS mVA
sympathetic parasympathetic HF
MS HF
mouse HF transition compensated LV_ hypertrophy HF hHD
chronic_Myocardial_ ischemia heart_ failure therapeutic
Spironolactone hyperkalemia acute_ kidney injury
EH renal impairment
jugular_venous_tension peripheral_ oedema volume
natriuretic_peptide biomarkers point_of_care
mechanical_ cardiac_ support renal_ function end-stage_heart_ failure
anticoagulants antiplatelet drugs heart_ failure atrial_ fibrillation
functional_metral_ stenosis ring_ annuloplasty ischemic_ mitral_regurgitation
heart implantationsLV_assist device implantations heart_ failure
heart_puissance_fraction clinical doppler_ echocardiography
patient_ safety
maladaptive_ moleculares
long-term
MI HF
HF-induced remodeling EMd prolongation
cardiovascular conditions HF
sustainability commissioning hospital- community-based programmes

HeartMate_ II LVAD
lVAD_support postoperative
Raf-MEK-MEK-erk1/2 signalling_pathway adaptive_maladaptive remodelling
hereditary_congenital_ abnormalities heart nontraumatic_ death
health_ insurance_de_health_system_de_distribution ues Food_de_ Drug Administration
bisphosphonate heart_ failure
ventricular_ longitudinal_ systolic_ strain cardiovascular events atrial_ fibrillation
Xanthine_ oxidase_ inhibition ventricular_synchrone_synchrone_synchrone_synchrone_synchrone
immunodetection NT-proBNP antibodies
PD complications therapy
spironolactone systolic_heart_ failure
Nordic_ walking cardiac rehabilitation
aortic_ valve surgery new-onset_ post-LVAD
medications heart_ failure NCDR PINNACLE
Heart_ failure medicine atheromatous_ coronary disease
HFpf
HFpEF
unloading_de_heart
réseau Cytoscape functional_ enrichment DAVID
circulation_mediator_de_ insulin_ resistance human monocytes inflammatory stimuli
hypertension diabetes ischemic_ etiology socioeconomic status
NT-proBNP
oxidative_stress GTPase_ Rac1 hearts ANS_mice
Heart_fréquence_de_fréquence HF
right heart_ circulation
Fontan_ circulation skeletal_ muscle_ mass metabolic
mineralocorticoid receptor
Fontan circulation sVR cardiac index pediatric cohort
HF cRThazard
palliative_de_ patients
rehospitalization medicare fee-for-service_ beneficiaries skilled_nursing
lVAD biventricular


cardiovascular_ death urgent_ cardiac transplant
clinical_prognostic diastolic_ dysfunction HFPEF
HF hpf hypertension
myocardial_ischemic events cardiac resynchronization therapy
parasympathetic tone pyridostigmine ventricular_ dysfunction heart_ failure
NT-proBNP HF patient_ plasma immunoprecipitation mass spectrometric
β-Blockade cardiac_ angiogenesis heart_ failure VEGF signaling_pathway
efficacy_ end points NYHA_ functional class quality-of-life
chrmatin_associated proteins chromatin_ structure DNA gene expression
heart_ failure HF Heart_ Failure_adherence_retention_trialHART
nonselective beta-blockers cardiac_synchrone_ activity hemostasis heart_ failure
ventricle_overload stroke ventricular_ ejection_ time lVET
Myocardial infarction left_ anterior descending coronary artery occlusion
adrenergic_ receptor_blockade


psoriasis
stress conditions maladaptive remodelling heart
mortality LCx LAD two-vessel_ disease
pPR aCR CMS
Intravenous iron heart_ failure iron deficiency
RV_ dysfunction
lVET
ischemic heart_ failure
exertion therapeutic
robot-assisted gait therapy Lokomat_system heart_ failure
CHF patients emergency departmentED intubated
gut inflammation dietary interventions heart_ failure
heart_ failure Emergency_ DepartmentED ED volume
congestive_heart_ failure
mitochondrial structure
ET HDL_fonctionnement CHF-NYHA-IIIb
physician_ follow-up_de_discharge
CHF therapeutic interruption_de_activated_ neurohormonal systems
implantation
microRNAs_miRNAs
implantable_ cardioverter-de_de_activation
pulmonary_ hypertensionPH heart_ failure
ambulatory HF ventricular ejectionfraction
Beta-blocker
QT_ variability QTV repolarization_lability QTV risk
implantation heart_ failure ejection_fraction
dialysis
mutant_mice_ overexpressing Hand heart_ muscles pathological_ hypertrophy
implanted New Zealand White rabbits renal DNx pacing-induced CHF
catheter ablation antiarrhythmic drugs rhythm_control therapy
technologies
RAS-blocker hFrEF HFpEF
Cardiac_ failure diabetes heart_ failure
transoesophageal_ echocardiography shunts thrombosis migration
arterial_ tonometry lVET precapillary_ PH heart_ failure
paraDIGm-HF chronic_ heart_ failure cardiology
Hemoglobin health status patients HF-action
ZSF1 rats heart_ failure preserved ejection_fraction
heart adipose_ tissue cachectic heart_ failure
Systems_protecomics cardiac chromatin nucleolin regulator_de_ growth cardiomyocytes
cardiac_ dysfunction subcellular alterations metoprolol heart_ failure myocardial infarction
mRI tidal_ respiration myocardial_ T1 swine heart_ failure
Myocardial collagen collagen_ cross-linking titin phosphorylation
heart_ magnetic_ resonance_ imaging chelation_ choices heart_ disease thalassaemia
LV diastolic_ dysfunction filling_tensions doppler_ echocardiography
Cardiac_ magnetic_ resonance_ postcontrast heart_ failure ejection_fraction

proteins
inappropriate therapy
Rhythm_control therapy
HF infancy adolescence
familiar physician index admission
Plasma HF

AMI mortality


aCS oHT bridged transplant MT VAD
psoriasis cardiovascular diseaseCVd
eseptal
HF conditions
cardiovascular disease dRS
pde_overexpressing cardiomyocytes norepinephrine-induced hypertrophic
association_de_frailty_de_fréquence_de_fréquence heart_ failure

heart_ failure bisphosphonates
GDMT BAT
RAS- β-blocker
Bax bcl-2 proteins
miRNAs cardiac remodeling heart_ failure
alendronate

regulation_de_ feeding nutritional anti-inflammatory effects CHF
clinical_disfonctionnement cause_ mortality
transduction_pathways
HF HF rheumatoid_arthritisRA
sandwich AlphaLISa immunoassays NT-proBNP
Blocker-induced cardiac_ angiogenesis therapy cardiac_function remodeling
figure
ambulatory ICD patients predictor mortality multivariable regression
Fes preserved_ ejection_fractionHFpEF
cardiotoxicity doxorubicin anti-neoplastic agent cancers
MT VAD aCS mortality morbidity
physician_ follow-up_ after_discharge physician_ continuity patients heart_ failure
sinus rhythm antiplatelet agents anticoagulants efficacy
c-statistics biological_ phenotype deficit
ventricular ejection_fraction
nicorandil cytotoxic effect doxorubicin solid Ehrlich carcinoma
implantable implantable_ cardioverter-de_fibrillator_de_activation
Renal_denervation dx CHF
LV_ diastolic_ dysfunction hff
natriure_peptides point_de_care ambulatory
Myxomas cardiac benign tumors
lifesaving drugs HF hrEF
lean ZSF1 hypertensive obese ZSF1 hypertensive diabetic
Gastrointestinal_ bleeding ventricular_assist devices
hyperkalemia acute_ kidney injury spironolactone
heart_puissance figure hospital_admission
bNP NT-proBNP coronary_ artery_de_capitaux
myocardial pde2 intracellular_antiadrenergic therapeutic HF
ventricular_éjection_fraction
ICU_admission precapillary_PH heart_ failure
Mammalian_ enabled Mena cytoskeletal_actin_ dynamics heart_ failureHF
refractory_congestive_heart_ failure peritoneal_dialysis
Heart_ failure hfff cardiovascular_ reserve
heart_puissance hff
Functional_metral_ stenosis m ring annuloplasty ischemic_ mitral_regurgitationMR
ARNI inhibitorsangiotensin-receptor_ neprilysin inhibitors
Myocardial loss IRS1 iRS2 heart_ failure MAPK insulin_ resistance
Heart_pererved_ ejection_fractionHFpEF cardiovascular_ morbidity mortality

peak_ aerobic_ capacity left-hand_ grip_ strength body_weight waist_ circumference anxiety


circulating_ forms NT-proBNP
PVf PB
eCG cRT
sst2 figure cardiovascular event
HF
figure VO2joint
benefits spironolactone
transfusions heart disease
breast cancer patients trastuzumb-related CHF
Kansas City Cardiomyopathy_ Questionnaire heart_ failure ejection_fraction
tissue doppler_ imaging left ventricular_ filling_puissance
heart_ failure_mice hypertensive heart_ disease angiotensin_ II infusion nephrectomy salt
pde2 failing hearts acute β-AR
Remote_monitoring_RM
pharmacologic
chronic_de_capitaux_de_capitaux
eGFR diuretics hypertension ESRD
RV dysfunction cardiac_ cachexia
temps-dependent ie heart_ failure hcRT-d
age-dependent
Mechanical_synchrony QRS_ complex cRT
clinicians anemic iron-deficient adult patients heart
carotid_ intima-media_ thickness psoriasis
psoriasis patients atherosclerosis cardiovascular events psoriasis
coronary occlusion collateral_ growth stent occlusion
aggressive dose_uptitration HR reduction beta-blocker
trastuzumab CHF nontrastuzumab
point-of-cares NP NP
EO-cFUs
isoprenaline infusion SDQT hNorm HF
HF remodeling EMd dyssynchronous_ failing heart
surgery HF hypertension vasodilators diuretics
acute_ heart_ failure aHF
aldosterone_ antagonist heart_ failure
angiogenesis post-myocardial_ infarction heart
arterial_compte TAC end-systolic_ elastance ees
heart_ failure ejection_fraction myocardial infarction
Renal_ dysfunction cardiovasculare
biventricular support HeartMate_ II lVAD CentriMag_rVAD
anthracycline congestive heart_ failure haematopoietique_cell transplantation
coronary_ artery disease systolic_heart_ failure
diabetes mellitus atrial_ fibrillation coronary_ artery disease HFpEF
Renal_ dysfunction long-term mortality myocardial infarction coronary artery_ bypass graftingCABG
Shunt implants transseptal catheterisation transoesophageal echocardiographic anaesthesia
lVAS
HDL_fonctionnement CHF ET HDL-mediated_ vascular effects
HF HF
physician adherence HF cPGs
TAC ees ivabradine- placebo-treated
ERC ERC epicatechin
hff
Care_management content-driven telehealth technologie
dopamine nesiritide
clinician
biomedical reasons_for_nonprescribing
black_race HF cardiovascular mortality
eGFR VAD ECmo_VAD
MEDLINE EMBASE cochrane clinical_tries
inability HF
Pyridostigmine vascular_endothelial_ growth_factor_ protein left ventricle myocardial_angiogenesis
baseline cRF HF mortality

Robot-assisted_ gait therapy Lokomat_system heart_ failure
elastic_n2bus_ segment PEVK
cardiac_ growth_ plasticity disease recapitulates chromatin remodeling
myocardium displays pKA
cXL-1020 converts hno inactive cXL-1051
proteomics chromatin-associated proteins detergent
CHF codes
idiopathic_ dilated_ cardiomyopathy
therapy atrial_ fibrillation carvedilol metoprolol
RV_ dysfunction body_ mass index figure cachexia
HeartMate_ II implantation
pharmacologic management acute HF
tNF_ antagonists HF hospital admissions nbDMARDs RA
Nicorandil mitochondrial dysfunction doxorubicin-induced heart_ failure cardioprotection
functional MS valve plasty degenerative MR LV
st-segment-elevation Killip conditions
HeartMate left_ventricular_assist_system lVAS
implantable_ cardioverter-defibrillator
baseline NT-proBNP MR-proANp MR-proADm
arterial_ elastance pulsatile_ afterload heart pressure
epidemiologie myocardial_ infarction m heart_ failureHF
brain_ natriuretic_peptide bNP creatinine natremia
management_de_ end_heart_ failure_ Heart_ failure public_ health
RAS hypertension nephropathy congestive heart_ failure
Isoelectric_ focusing RIα ser77 ser83 phosphorylation
Self-Care_of_ Heart_ Failure SCHFI psychometric profile
SDQT SD RR index QTV heart_ variability
Heart_reduction_de_ exercise_ performance heart_ failure ejection_fraction beta-blocker hypo-response
heart_ failure mechanical_support devices Cardiology-cardiovascular_surgery
HF PAf biosynthetic enzymes lyso-PAf-AT
physician adherence
voluntary testimonies nurses multisite

risk-adjusted_ mortality
ejection_fraction
HF complicating AMI
Physician_volume HF noncardiologist physicians
sst2/low-dose BB
grs
CHF
LV ejection_fraction PCWP hg

zebrafish nucleolin genomic_ reprogramming disease
eGFR VAD ECmo_VAD renale
cardiac_ magnetic_ resonance_ imaging invasive_hemodynamic assessments
mADIt-cRT multicenter_automatic_deibrillator implantation Cardiac_resynchronization Therapy
aUCs eeseptal e e e e e e eseptal QRs_width resynchronization
diuretics HF-related_ morbidity mortality
public_ health air pollution
hospital_s 30-day_ readmission_ rate heart_ failure
implantation gastrointestinal
carvedilol metoprolol inappropriate therapy heart_ failure devices
IVc occlusion twist apical rotation RS synchrony CS
Logistic_regression
heart_ failure HF inpatient_utilisation outpatient
Morbidity_de_ mortality HFpEF
congestive_heart_ failure
BET bromodomain-containing proteinBRd4 cardiac
molecular biomarkers pathophysiology chronic HF
emergency department acute_heart_ failure clinical_ trials enriching patient
intravenous_ iron
Medicare inpatient HF admissions acute_care hospitals
eCG congenital_accessory_ pathways ion_ channelopathies cardiomyopathy
mouse HF hh hh hh salt_ loading uninephrectomy ANG_ II infusion
mitral valve plasty degenerative mitral_regurgitation
Erythropoiesis-stimulation agents anemia heart
idiopathic_ dilated_ cardiomyopathy tuscany evidence-based management
in-trial resource_ utilization Québec Health Insurance Board disease-specific costs Ontario Case Costing
HF preserved ejection_fraction pEF hospitalisation
HFheart_ failure T2d diabetes Skm skeletal muscle
RAS RAS neprilysin_ inhibition chronic_ heart_ failure systolic_ dysfunction
tidal_ respiration gadolinium-chelate_ contrast agent
HF HF pyridostigmine basal heart_ rate vagal sympathetic_control_de_ heart_ rate
DAPcdystrophin-associated_ protein complex sarcomeric microstructure
cardiopulmonary_réquence_de_ life score muscular_ strength peak quadriceps force
dopamine nesiritide acute_heart_ failure renal dysfunction acute_heart_ failure
catheter ablation atrial_ fibrillation heart_ failure ejection_fraction
Myocardial titin hypophosphorylation heart_ failure rat metabolic risk
AF ablation
ejection_fraction
économique models lVAD
echocardiographic score cRT

HF HF HF HF mis preserved ejection_fractionEF
HeartMate_ II lVAD temporary CentriMag RVAD
HFpEF kccq
Chronic_heart_ failure transforming growth factor_ beta-dependent_ yield atrial explant-derived c-Kit_cells
Mortality inpatient_admissions hospital_ days emergency department_ED
RV ventricular dysfunction
baseline serum_ creatinine figure serum_ potassium
PD_ initiation diuretic_ response peripheral edema functional
anemia chronic_heart_ failureHF
If-channel_ inhibition hemodynamic status tolerance heart_ failure preserved ejection_fraction
Cardiac_ insulin-resistance mitochondrial_énergie production systolic heart_ failure pressure-overload hypertrophy
echocardiographic predictors cardiac_resynchronization_therapy cRT
circulating NT-proBNP antibodies nonglycosylated nonterminal epitopes
implantation structured_réquence_réquence
hf hf hf hf hf hf hf hf hf hf hf hf hf hf hf hz hz bpm beta-blocker therapy
vent-stage_heart_ failure pediatric mechanical_ cardiac support
nbDMARD TNF_ antagonist baseline
Hum-retn cardiac mRNA inflammatory cell_ adhesion_ genes Retn
PAf metabolic_ enzymes heart_ failure
chromatin_subproteomes heart_ failure
heart_ failure nurses cardiology services mortality
pyridostigmine administration methylatropine propranolol cardiac_ sympathovagal_ balance
preoperative renal dysfunction stroke myocardial infarction heart_ failure CABG
myosin_binding_ protein-C phosphorylation Ser23/24 troponin phosphorylation HF
trastuzumab cardiotoxicity congestive_ heart_ failureCHf
Phosphodiesterase-2 failing hearts blunts beta-adrenergic cardiomyocytes
cox hazard_modellen temps ESRD death ESRD

deactivation
costs
nutritional abnormalities CHF fat carbohydrates proteins water
doxorubicin serum_ resistin Hum-retn mice
pigs inferior vena_cavaIVc CO
mva
University_de_ Connecticut Heart_ Failure Center cardiologist heart_ failure nurse_practitioner
XO inhibition cardiomyocyte_ bioenergetics LV chronic ACF rat
heart_ failure HF cardiopulmonary_exercice anaerobic_ threshold
uPR protein kinase ER kinaseperk calreticulin CHOp HF
carvedilol thromboembolic events heart_ failure β2-receptor_haplotype
HF HF pyridostigmine stroke_ volume ejection_fraction cardiac_ output contractility ventricle
ecardiographic measures pro-brain_ natriuretic_peptide inflammatory markers
randomised-controlled trialsRCts
aldosterone_ receptor_ antagonists
économique_ climate NHs behavioural-change implants chronic_ disease
dialysis-dependent HF cRT implantation
VAD ECmo+VAD
Women_s_ Health Initiative HF
hct hct City_of_ Hope
RV
oxygen_puissance
CV_ deaths non-fatal_ stroke hospitalisations heart_ failure
middle-aged_ recreational_ athletes sudden_ cardiac deaths atherosclerotic CAD
biomarkers molecular dysfunction chronic HF
Ambient air pollution cardiovascular_ health acute_Myocardial infarction
eAST rhythm_control therapy AF cardiovascular complications AF
sCN5a transcript uPR downregulation_de_multi_ cardiac genes HF
HF
sensitivity CAD sensitivity
albumin inflammation hepatic implantation
pasp figure
mAIN mAIN mAIN_ oUTCOME_measuures gLS index_ beat CV cox proportional_ hazards
hearts Mena cardiac injury HF
Olmsted County Minnesota MI HF
CHF infarction animals left ventricle_ end-diastolic_tension hg scar
biomarkers heart_ failure
Lipolysis energie_ expenditure natriuretic peptidesNPs CC
neurohumoral blockers HF co-morbidity
kccq Kaplan-meier curves
Right ventricular RV insertion left ventricular_assist device lVAD
odds_hazard ratio HF AMI
Testosterone_therapy_active_rehabilittion male patients chronic_heart_ failure testosterone
cox proportional_ hazards
AMI heart failure kidney infection UTI
ST2 reclassification_de_risk c statistic discrimination
RAS doppler_ ultrasonography tomographic angiography magnetic_ resonance_ angiography
cRT-d IE defibrillator-only therapy

lVAD implantation_ eligibility
hypoalbuminemia postoperative mortality left ventricular implantation
ventricular_éjection_fraction long-term_ mortality heart_ Failure
renal_ underperfusion renin- angiotensin-aldosterone
atrial_ fibrillation atrial_tachyarrhythmias ATP shock therapy
percutane_ coronary_revascularization hemodynamically
nicorandil cardioprotection apoptotic signaling pathway DNA_ fragmentation mitochondrial_ ultrastructural changes
diabetes_ mellitus metabolic_risk conditions heart_ failure ejection_fraction
proteomics pressure-overload-induced heart_ failure mitochondrial-targeted peptides
inhibition vascular_endothelial_ growth_factorVEGF transition compensatory_ hypertrophy cardiac
IC multicenter_automatic_deibrillator implantation_trial-Cardiac_resynchronization Therapy
speckle_tracking echocardiography ste biVP ventricular_tensionRVPO
Cardiopulmonary echocardiographic assessment myocardial_fréquence ventricular filling
Health Buddy_program chronic_ obstructive_ pulmonary disease mortality congestive_ heart_ failure
HR_dynamics temps-domain HR variability risk
HF index AMI
LVEF
uPR na+ channel mRNA splice cardiac_na+ current HF
diuretic_ efficacy neurohormonal_activation congestion-like fluid_overload
apoptosis pathogenesis_de_ heart_ failure
BETs transcriptional_ pause_release transcription
implant_fractional_shortening lung_weight
sex EF bNP HF bNP
dose_uptitration HR
eCG atherosclerotic CAD sudden cardiac death
incident_synchron_heart_ failure spironolactone hospitalization
PERK mRNA mRNA splice
dysfunction rad_variant congestive_ heart_ failure
implantation programmed_cell_ death DEGs
Mena expression HF HF cardiac_pathophysiology
controlled_ randomized trials
RECENT_ FINDINGs intestinal morphologie permeability absorption_ function CHF
NP
Trastuzumab CHF
atrial_fibrillationAF heart_ failure HF progress_ in_ anticoagulation
Fontan_ failure circulatory_derangement hemodynamic portal_ hypertension augment cardiac output
echocardiographic score LV reverse remodeling
LVEF long-term mortality acute_decompensated HF
bottleneck stent timing myocardial infarction antiplatelet medication
salt_ loading uninephrectomy ANG_ II infusion cardiac_fonctionnement HF
biventricular support HeartMate_ II lVAD CentriMag ventricular_assist devicerVAD
Blood_tension arm_ cuff stroke_puissance ejection_fraction end-diastolic_ volume echocardiography
fibrosis_de_ heart_ failure_Myocardial_ tissue left ventricular_ tissue trichrome blue histologic
Kansas City Cardiomyopathy kccq HF hpEF
implantation implantation atrial_fréquence implantation atrial_ fibrillation Stroke_ prevention
annular plane_synchrone_excursion pulmonary_ arterial_ systolic_tension heart_ failure ventricular_contractile
high-volume physicians

HF
cardiac hypertrophy nucleolin
myocardial DD muscle_ strip_ stiffness titin hypophosphorylation
ventricular RV
ARNI cardiovascular mortality hospitalization_for_heart_ failure quality_of_ life
functional MS valve plasty annular size_ reduction degenerative MR LV dilated disease
EO-cFUs CD34_vegFR2_cells
HF-action hgb baseline HRQoL kccq
Frailty heart_ failure h biological phenotype accumulation_de_ deficits
functional MS valve plasty degenerative MR LV
idiopathic_ dilated_ cardiomyopathy
pathological remodelling heart cardiac hypertrophy HF fibrosis inflammation
peak_puissance figure

virtual cohorts coût-effective

RAS- β-blocker hFrEF HFpf hospital admission
American College_of_ Cardiology_American_ Heart Association RAS
NT-proBNP plasma dyspnea left ventricular_ dysfunction ED
implantable implantable cardioverter-de_defibrillator_de_activation
Circulation_progenitor cells cPCs endothelial_ repair cardiovascular
contractile_function LV_dilatation LV end-diastolic_tensionwall_ stress lung_weight
LV remodeling diastolic properties XO
Caucasian sNP rs10927887 Ka renal_ chloride_ channel_ geneCLCNKA
ventricular_assist deviceVAD extracorporeal_ membrane_ oxygenation emo renal
cardiac magnetic_ resonance amyloidotic_ pattern_de_multi myeloma osteomedullary biopsy
HFpEF echo-Doppler_cardiography invasive haemodynamic assessment
implantable implantable implantable_de_de_fibrillatorsICds cardiac resynchronization therapy cRT mortality
Vascular_endothelial_ growth_factor_blockade beta-blocker therapy cardiac angiogenesis remodeling heart_ failure
low-sodium DASh diet ventricular-arterial coupling hypertensive_heart_ failure ejection fraction
bt DT coût-effectiveness
expenditure health_per capita gross_national_ income HF
blood pressure_control lipid-lowering therapy smoking_ cessation RAS
bNP inhospital_ mortality
SDQT HFVT hNorm figure fixed-rate_atrial_pacing
cRT-d
af pharmaceuticals hFPEF

hff
Physician volume HF
diffuse_Myocardial_ changes heart_ failure contrast agent breath-holding
eplerenone HF-ref hyperkalemia WRF
hg pasp
RM
implantable implantable_ cardioverter_de_fibrillator-CRT
QRs morphologie cardiac_resynchronization_therapy cRT
reactivation embryonic_ gene programs pathological_ heart disease transcription factors
mDC
sst2/low-dose BB sst2/high-dose odds ratios cardiovascular events
centrifugal_ flow_pump hemocompatibility magnetically levitated rotor blood-flow_paths artificial_ pulse
biomedical treatment CHm biomedical treatment dCM heart_ failure
multiparametric echocardiographic score reverse remodeling cRT
patient_ categorization emergency_ department acute_heart_ failure aHF
Yorkshire swine implanted pacemakers ventricularly paced
heart_reduction ivabradine patients systolic_heart_ failure
mitochondrial_ complex_V activity aac phosphocreatine ATP
skeletal muscle_ sarcomer structure heart_ failure diabetes epicatechin-rich cocoa
ST2 cardioprotective_ signaling myocardium biomarker_ in_heart_ failureHF
MI metoprolol plasma norepinephrine dopamine epinephrine
Cardiovascular outcomes Renal_ Atherosclerotic_ Lesions CORAL stenting RAS
implantable_ cardioverter_de_fibrillateursICds
Mediterranean Dietary_Approaches Stop_ HypertensionDASh mortality postmenopausal women HF
NP

électronique databases MEDLINE EMBAse PsycINFO
patient-level_regression risk-adjusted_ mortality readmissions costs patient physician hospital
LBBB implantable implantable_ cardioverter_de_fibrillator-CRT
echocardiography cardiac_ diameters b-treated
quality_of_ life functional_capacitation
therapeutic left-to-right interatrial_ shunting heart_ failure ejection_fraction
heart_ failure hypertension mitral_ regurgitation mitral stenosis
antagonists renin-angiotensin-aldosterone sympathetic_ nervous systems CHF
implantation pulmonary hypertension ventricular_contractile_ reserve
cardiovascular_ death heart_ failure myocardial_ infarction
implantable implantable cardioverter-defibrillator Heart_ Function Clinic University_ Health NetworkToronto
PERK_activation destabilized SCN5a kv4.3 mRNAs transient receptor_potentsiaal cation channel m7TRPM7) mRNA
Cardiac-resynchronization_therapy cRT morbidity_de_ mortality chronic_synchron_heart_ failure QRS
systolic HF HF left_ right heart_ filling_tensions systemic_ vascular_ resistance cardiac stroke
HF HF HF epidemiologie SH cd rheumatic fever
caloric restriction_diet aerobic exercise_training_exercise QOL hff
cardiac_Myocyte_specific Mena_overexpression tgtetMena cardiac_pathology
inpatients heart_ failure hospital_discharge
baseline hgb kccq hgb hgb
HFpEF diastolic_ filling temps heart_ rate
chronic_heart_ failure HF hemodynamic disorder syndrome dysfunction interconnected_ molecular pathways
Right_ Heart_ Foundation
guideline-recommended medications patients heart_ failure ejection_fraction
truncated na+ channels unfolded protein response uPR SCN5a electric remodeling HF
cardiac hypertrophy pressure-overload abdominal aortic_constriction aac
antiplatelet agents anticoagulants vascular diseases
allopurinol LV contractile_fréquence XO-mediated ROS myofilament
ankle-brachial index pulse-wave_ velocity coronary artery calcium scores
myofiber dynamics myofiber_shortening EMd dyssynchronous HF
Fontan_ failure hemodynamically heart_ failure systemic_ vascular_ resistance sVR cardiac index
figureffff
physical activity cRF HF

rehospitalization Medicare hospital_ claims Medicare post-acute_care_transfer_policy

therapy comorbidities
therapeutic af in patients_contre_heart_ failure financière
physicians management patients advanced_heart_ failure therapeutic
risk_de_heart_puissance etidronate alendronate
metabolic_ exercise cardiac kidney index score
ET HDL-mediated_protecive effects molecular pathways chronic_heart_ failureCHf
β-adrenergic receptor_blocker therapy myocardial_perfusion neoangiogenesis failing heart
interagency_ Registry_ for_ Mechanically_assisted_ Circulatory_ Support
ventricular_éjection_fraction ventricular_ diastolic_ end
ventricular_ ejection_fraction heart_ failure fractionHFpEF
ventricular_ hypertrophy heart_ failure
sCN5a angII hypoxia uPR
HF hyperkalemia hypokalemia spironolactone
implantg techniques HFpEF long_axis_fonctionnement
g-protein-coupled receptor_ kinase
NT-proBNP
dopamine nesiritide decongestion renal
bNP
hART hART HF hf hf HF hrf hrf
HF HF fréquence 28-day mortality hazard
extracellular_ matrix left ventricular_ biopsies tissueFAXs technologie
ventricular_assist devices lVADs patients advanced heart_ failure pump
bone_ morphogenetic protein rRNA transcription heterochromatic chromatin
biomarker anthracycline_induced_ cardiotoxicity heart_ failure macrophages
actin_ cytoskeleton mitochondrial metabolism glycolysis_gluconeogenesis citrate
conscious dogs tachypacing-induced HF contractility end-systolic elastance venoarterial dilation
ST2 amino-terminal_pro-B-type natriuretic peptide
diagnostics clinical
alndronate etidronate raloxifene
implantable implantable_ cardioverter_de_fibrillator-CRT LBBB QRS
kccq figure HFpEF

saxagliptin sitagliptin
literature anemia iron_deficiency MEDLINE cochrane Library
Sprague-Dawley sham aCF allopurinol
sst_de_high-dose BB
myocardial_ collagen
biomedical treatment CHm biomedical treatment dCM heart_ failure PubMed
creatinine bNP furosemide dose oxygen flow dobutamine norepinephrine
biventricular_pacing biVP cardiac_co cardiac surgery
contemporary_heart_ failure HF therapies HF preserved left ventricular_ ejection_fractionLVEF
systolic HF Danish Heart_ Failure ESRD Danish Registry_ on_Dialysis
Chemotherapy trastuzumab CHF Healthcare_ Common_ Procedure codes
implantation
cRT figure hazard ratio
neurohormones adipokines body_constitution CC fat_ free massfm fatFM
expression mistargeting rad Q66p RGK_ protein efficacy in vivo
restoration cardiac_ plasma membrane S1PR1 deleterious β1AR overstimulation heart_ failure
AlphaLISa immunoassays antibodies c termini circulating NT-proBNP
fully magnetically_ levitated lVAS mortality_risk Seattle_ Heart_ Failure
Myocyte_ hypertrophy_ antecedent_to_ heart_ failure gene expression
catheter ablation_for_ AF compensated hfff ventricularLV ejection_fraction
New York_ Heart_ AssociationNYHA class_ III chronic_heart_ failure ejection_fraction Canadian
Swedish_national_inpatient_ Registry rehospitalization stroke myocardial infarction heart_ failure CABG
Hospitalized_ Heart_ Failure Saxagliptin sitagliptin antihyperglycemic Drugs
cox proportional_ hazards score implantation LV_assist_ device_ implantation heart
Nicorandil phosphocreatine adenine nucleotides mitochondrial oxidative phosphorylation creatine kinase
intraclass correlation_coefficientICc kappa coefficient mDC
Race_training chronic_heart_ failure Heart_ Failure
cardiomyocytes mechanical humoral stimuli myocardium conditions
biventricular_support
BB therapy
CHF cardiac explant c-Kit_progenitors
ESRD inpatients systolic HF eGFR
transitions_de_capitaux self-management techniques out-patient_ follow-up
functional_ efficacy hno hno_ donor myocardial_fonctionnel HF
TUnel_assay apoptotic cells
gain_force RV_ dysfunction
biological_ phenotype deficit_ index medical_ records
tachycardia intravenous atropine cardiac_vagal tone CHF-DNx CHF-INV
transitions_de_capitaux congestive_ heart_ failure
HH medical_support office_ hours mortality
surgically induced myocardial infarction heart_ failure bisoprolol vehicle
SDQT HFVT hNorm β-adrenoceptor blockade esmolol
implantation_de_rémission_ rates heart_ failure HF acute_ myocardial infarction pneumonia
Peritoneal_dialysisPD diuretic_ resistant_ volume_ overload heart_ failure
hno_ donor cXL_-1020) intact hearts HF
Peripheral artery diseasePAD heart_ failure HF
heart_puissance hfff heart_puissance
Renal_ dysfunction heart_ failure HF dysfunction end-stage renal diseaseesRD
Nicorandil heart rate aortic blood flow mitochondrial oxidative stress doxorubicin cardiotoxicity
peripheral muscle_pump cardiac_ filling subpulmonary ventricle Fontan_ circulation
echocardiographic score LV reverse_ remodeling LV end-systolic volume
Cardiovascular_ Disease Registry_ Practice_ Innovation Clinical_ Excellence
ventricular_éjection spironolactone Kaiser Permanente Northern California
bmi heart rate rhythm lying standing blood_tension valvular_ disease pulmonary_congestion
myocardial_ extracellular matrix cardiac_ magnetic_ resonance_ T1 pathobiology_pathophysiology prognosis
left-to-right interatrial_ shunting patients heart_ failure ejection_fraction
aldosterone_ antagonist therapy heart_ failure post-myocardial infarction_ heart_ failure
preoperative renal dysfunction cardiovascular eventsstroke myocardial infarction heart failure
clinical heart_failure CHARM programme candesartan_ in_ Heart_ Failure Mortality Morbidity

protocol-driven POC NP patient consultation ED throughput
physician_ volume_de_ mortality internists cardiologists
shuttle_walk_test body_ mass hand_grip_ strength
capillary_de_ coronary_perfusion b-treated ad-flk rats
cell senescence active malignancies cancer prostate colon osteoporosis depression
leaflet serial evaluation MS subvalvular annular MS
strength_de_race long-term_ outcomes contemporary_ chronic_heart_ failure HF exercise
pediatric Fontan PF
mRI-based models dyssynchronous_nonfailing HF canine_électromechaniques remodeling
anemia HF health-related_quality_of_ lifeHRQoL HF
obese hfff caloric restriction aerobic_ exercise
implant-derived_progenitor_cells
Lancet air pollution heart_ failure morbidity mortality
HR_ variability mortality AMI CHF/LV
Troponin_t n-terminal_pro-B-type natriuretic_peptide biomarker heart_ failure_risk atherosclerosis
ventricular_assist devices cardiac nurses management gastrointestinal_ bleeding
cardiac transplant eCT transplant pool
prospective HF HF HF eff HFpEF
mortality cardiovascular_ mortalityHF
American College_of_ Physicians aCP anemia iron_deficiency
BAT N-terminal_pro-brain_ natriuretic_peptide HF
septum_systolic_ thickness LV posterior_ wall_ thickness LV internal_ diameter metoprolol
tachycardic_ response methylatropine vagal tone bradycardic_ response propranolol sympathetic tone
cox regression spironolactone
acute RV_ failure chronic pulmonary_ arterial_ hypertensionPAh acute pulmonary_ embolism
mitochondrial_oxidative_phosphorylation_puissance creatine kinase activity oxidative_stress markers DNA
cardiac_resynchronization therapy cRT mild heart_ failure HF QRs ejection_fractionEF
Fractional_ flow_ reserve positron emission_tomography_ imaging ischemia bottleneck stenting left ventricle proximal LAD
économique_analysis Patient_Management_ Interventions Heart_ Failure Cost-Effectiveness
Neprilysin_ inhibitors natriuretic_peptide breakdown atrial_ natriuretic_peptide b-type natriuretic_peptide
electrical stimulation peripheral muscles endothelial function heart_ failure ventricular ejection fraction
SDQT-to-SDRR HFVT hNorm
ventricular structure fibersheet orientation handling slowed conduction wall stiffness
rad Q66p cardiomyopathy
serum_ resistin women anthracycline-containing_chemotherapy cardiotoxicity
sst figure cardiovascular_event_ rate
preoperative hypoalbuminemia
renin-angiotensin_system_ blocker beta-blocker therapy heart_ failure ventricular ejection
Medical Therapies Cardiac_ Function Breath Lung_congestion
nurse cognitive impairment hospitalization physician discharge elderly patients heart_ failure
patients_with_ advanced_heart_ failureheart_team cardiologists cardiovascular surgeons medical
HF-action HF HF ejection_fraction
bisphosphonates alendronate etidronate risk_de_heart_ failure refill
acute RV_ failure pulmonary_ embolism mortality
TAPse PASp nonsurvivors hFrEF hfpEF
Chinese_ herbal medicineCHm adjunctive treatment dilated_ cardiomyopathyDCm heart_ failure
Baroreflex_sensitivity time_ domain heart_ rate_variable hv CHF-inv sham-inv renal DNx
hypertension hg diabetes mellitus systolic murmurs
cardioprotective_effet nicorandil hemodynamic_ alterations mitochondrial dysfunction doxorubicin rats
electrical_activation dyssynchronous_ heart_ failure HF electromechanical_ behavior
in vivo inhibition miR-25 spontaneous cardiac_ dysfunction murine_myocardium heart_ failure Hand2-dependent
NT-proBNP
epigenetic_writer proteinshistone acetyltransferases epigenetic_erasershistone_deacetylases cardiac
haematopoietique_cell transplantation hCT congestive_ heart_ failureCHf pre-HCT anthracyclines
carvedilol β-blocker β-blocker metoprolol thromboembolic
HF AMI pna mortality

dietary_ recommendations patients heart_ failure HF
implanting arrhythmia_ substrate AMI HR_ variability
hypertension compensated HFPEF DASh_sRD sodium
emd dyssynchronous HF remodeling
ejection_fraction cardiac index inotropes inotrope
doxorubicin-induced cardiotoxicity Hum-retn littermate resistin
diastolic_ dysfunction pathophysiology HFpEF
fluo-cAMP binding phosphomimic Ser83 mutant RIα double_mutant WT_riα
High-density lipoproteinHDL endothelial-protective effects endothelial cell nitric oxide
Dialysis HF hospitalization
admission_discharge hospitalized_ older adults heart_ failure Nursing_outcomes_ Classification
hf saxagliptin sitagliptin antihyperglycemic agents
preoperative albumin mortality lVAD implantation
systolic_ heart_ failure QRs cRT hospitalization_for_heart_ failure mortality
ddegs non-ischemic ischemic heart_ failure healthy
bleeding driveline_ infection gastrointestinal bleeding debilitating stroke
cox regression models propensity score_decile oral glucocorticoid HF loop_diuretics
insulin_ resistance diabetes insulin receptor substrates iRS insulin-signaling
dyssynchronous HF electromechanical_delay emd myocyte_depolarization myofiber
Beta_blockers mortality readmissions heart_ failure ejection_fraction hrEF heart_ rateHR
Functional_ electrical_ stimulation fes exercise_ capacity emotional stress endothelial_ function chronic heart_ failure
right atrial_Myxoma pulmonary arteries right_ atrial_ mass_ removal pulmonary embolectomy
transplant ineligible patients HF volume_management
statistical standards biomarker-guided_ clinical_ trial therapeutic
SAF abnormal liver_ textures
Frailty biological_ phenotype weak grip_ strength physical_ exhaustion slowness activité
cRT-d IE IC cRT-d
volume EDs heart_ failure_home
QRs morphologie cardiac resynchronization_ therapy Resynchronization-Defibrillation Ambulatory_ Heart_ Failure_trialRAFt
acute_ right heart_ failure therapy_ refractory_ cardiogenic shock heart_team extra corporeal_ membrane_ oxygenation cPR ICU
office-based emergency room_practitioners children undiagnosed heart disease HF surgical palliation
Bax bcl-2 mRNA heart_ failure bcl-2/Bax
heart_ magnetic_ resonance_ imaging chelation_ choices patient_conduite
nitroxyl hno Angelis salt inotropic lusitropic vasodilator cAMP
ejection_fraction_f pre-PD NYHA class_ IIIb ventricular_ dysfunction
cPCs early-outgrowth colony-forming unitsEO-cFUs circulating CD34 vEGFR2 CD133
clinical_effectiveness continuous-flow_laVADs heartMate_ II HeartWare bTT DT
anticoagulation rate_control cardiovascular complicationsstroke cardiovascular death acute_ heart_ failure atrial_ fibrillationAF
baseline EF
bp inhospital mortality
DASh mortality HF
skeletal_skeletal_tension figure
ST2 functional_ capacity well-treated ambulatory patients HF
Quality_of_ life all-cause mortality
implanting cultured_ cardiomyocytes jq1 drug phenylephrine-induced genes
CLCNKA polymorphism heart_ failure glomerular_ filtration_ rate RENASTUR
cardiovascular diseases heart_ failure HF
cardiac_veGF expression Akt endothelial_no synthase_activation drug-untreated failing hearts
Psychosocial Factors Heart_ Failure Heart_ Failure HF-ACTION
heart_ failure left ventricular_synstolic_ dysfunction BB
derivation_cohort coronary_ angiography systolic HF unclear etiology
cardiac_ insulin-resistance aac insulin-stimulated rates glycolysis glucose oxidation plasma membrane translocation glucose transporter
angiotensin II angII hypoxia activateurs sCN5a mRNA splicing
ventricular_contractile_ reserve
arterial_ elastance end-systolic elastance ventricular-arterial coupling ratio ees
DASh_sRD brachial_central_ blood_tension radial_ arterial_ tonometry cardiovascular echocardiographic
Gene_expression_profil gse9128 Gene_ Expression_ Omnibus ischemic heart_ failure
rhythm_control therapy antiarrhythmic drugs catheter ablation electrocardiographic device rhythm
hospitalisations implantable cardiac_arrhythmia devices noncardiovascular drugs
HF HF HF HF_de_réquence_fraction hrEF
extracorporeal_ life_support bridging therapy acute ischemic_ right heart_ failure refractory_ cardiogenic_ shock reperfusion therapy
heart_ failure left ventricular_ ejection_fraction Fes exercise_capacition emotional status endothelial_ function HFpEF
intubation
hearts TTA tgtetMena mice wild-type_ littermates heart_ mass transgenic mice
raloxifene
hFrf respiratory_gas
guideline-recommended drugs heart_ failure biomedical reasons
black race HF
Wasting_de_ fat lean_ mass fat_ loss enhanced catabolism adipose_ tissue cardioprotective HF
lVADs implants hVAD hVAD intl Framingham Mass
hearts_de_ fish_ lacking Nucleolin chamber_ patterning_des_fonctionnements defects cardiac_ looping myocyte
HF immunoreactive NT-proBNP
FM plasma NPs adiponectin FFM NPs adiponectin
cardiomyocytes Hum-retn doxorubicin hretn hretn mRNA protein expression
beat-to-beat QT figure surface ECGs atrial pacing esmolol isoprenaline atropine infusion
withdrawal_de_ sympathetic tone parasympathetic_ tone heart_ rate metoprolol atropine
EH HFpEF hff hff hff hff
adverse event_ rates acute_Myocardial_ infarction congestive heart_ failure

hospital_quality_ improvement
cardiac_ tissue TAC- sham-operated jq1 BET_ inhibition_ suppresses pathological_ cardiac_ gene expression
Power_ spectral_analyse low-frequency_high-frequency hf CHF-inv sham-inv sham-inv
N-terminal pro-B-type_ natriuretic_peptideNT-proBNP misdiagnosis_de_heart_ failureHF
HF-action ventricular_ ejection fraction New York Heart_ Association IV HF
myocardial DD collagen_deposition titin modification diabetic ZSF1 rats heart_ failure
cardiac_ magnetic_ resonance hFPEF biomarker hFPEF
ventricular-arterial coupling ivabradine-treated
conditional gene-targeted Hand pressure-overload-induced hypertrophy fibrosis ventricular_ dysfunction fetal gene
figure admission NT-proBNP prescriptive 4-year_ survival ED acute HF
clinical_ prediction_ rule CAD angiography systolic HF cost
epigenetic readers cardiac_biology cardiac_control chromatin-dependent signal_transduction abrogate pathological_ gene expression HF
Systolic_ blood_tension left ventricularLV hypertrophy AN ANS
heart_ failure sudden death noncardiac cardiac transplant
catheter-based percutaneous_revascularization angioplasty stenting
load-corrected chronotropic figure heart rate
oxygen_puissance
cox-proportional hazard models negative binomial regression models intervention survival_ utilization demographic health
HF HF t2d ERC treadmill_ testingVO2max oxygen_ consumption Skm biopsies
hospital gastrointestinal_ bleeding ventricular_tachycardia storm terminal
β-AR stimulation catecholamine infusions pde2 cAMP hydrolytic activity blunted_ cardiac β-AR responsiveness
HF QRs prolongation LVEF cRT reverse remodeling
chronic PAH hospitalized RV_decompensation pharmacologic therapies RV_ failure_management PAH

comanagement clinicians patient_adherence medication
non-frail figure Gill HF
frailty Health ABC_short_phyal_ Performance_ Battery hABC_battery Gill index HF
RV RV lVAD_insertion cardiogenic_ shock myocardial infarction chronic_decompensated_heart_ failure
Chronic_heart_ failure chf multisystem_disquence anemia insulin_ resistance autonomic_ dysbalance cardiac_ cachexia
Xanthine oxidase XO rat left ventricularLV myocytes volume_ overload mitral_ regurgitation aortocaval_ fistula
obese ZSF1 heart_ failure lung_ weight ventricular ejection_fraction left ventricular DD
high-volume physicians low-volume
Western_européen_linked_administrative_ health figure HF AMI
conditions
nursing-sensitive outcomes
HF AMI
miRNAs RNAs RNAs binding messenger RNA
free-breathing pulse_ sequence myocardial_ T1 swine_model tachycardia-induced heart_ failure
HFpEF ivabradine
PF_cohort New York_ Heart_ Association
eds diagnosis_de_heart_ failure
Cardiac c-Kit cardiac explant-derived cells
pathophysiology HF medical management
inhibitor BETs chromatin RNA_polymerase_ IIpol II
NPs pulmonary_ embolism diabetes
empirically_ derived composite quality_de_heart_ failure HF acute_méocardial infarction pneumonia pna
intestinal_disfunction disturbed intestinal_ barrier chronic_ inflammatory_ state catabolic_anabolic imbalance cardiac cachexia CHF
epidemic heart_ failure preserved ejection_fractionHFpEF
cyclic adenosine_ monophosphate cAMP augmented cyclic guanosine_ monophosphate cgmp
mortality healthcare_ utilization techniques care management telehealth congestive_heart_ failure chronic_ obstructive_ pulmonary diabetes mellitus
efficacy catheter ablation atrial_ fibrillationAF heart_ failure hfff
ischemic-hypertensive cardiomiopathy angina inducible myocardial ischemia coronary arteries
RA methotrexate TNF_ antagonist non-biological disease_modifying antirheumatic drugnbDMARD
cox proportional hazards_regression_modelling ie acute_ coronary syndromes coronary interventions
sphingosine-1-phosphate receptor s1PR β1-adrenergic receptorβ1AR g-protein-coupled
septal PCWP
inappropriate therapy atrial_ fibrillation carvedilol metoprolol
gLS LVEF sa in predicting adverse CV
Bradycardia implanted metoprolol cardiac_ sympathetic tone CHF-INV sham-INv CHF-DNx
cPG-recommended pharmacological treatment device
Nordic_ walking standard_ cardiac rehabilitation_de_capitaux_de_fonctionnement
Rad Q66p inhibitory actions Rad caV1.2 l-type_ channel_isoforms heart
EF LCx LAD LAD figure infarcted left ventricle LCx LAD
signalling cascades microRNAs bHLh transcription_factor Hand2 postnatal_ mammalian_ myocardium embryonic_ gene programs heart_ failure
ERC ERC DAPc protein_ levels sarcomeric microstructure Skm growth myofibre regeneration
mva surgical_ ring implantation leaflet_ motion leaflet_ resection edge-to-edge anastomosis
hART New York_ Heart_ Association NYHA HF HF
BET_bromodomain proteinsBET acetyl-lysine_ reader_ proteins HF
cardiac_fonctionnement echocardiography diastolic_ dysfunction E/E dysfunction ejection_fraction
aldosterone_ antagonism_ in_ heart_ failure aldosterone neurohormone electrolytes
EH LV_de_capitaux_puissance LV_de_capitaux_puissance hg coefficient ml
Grading_de_recommendations EvaluationGRADe
HF
implantation_de_fréquence right heart_ circulatory_ failure
influx l-type_voltage-gated ca figure ventricular action é coupling
AT1 receptors neprilysin blocks renin-angiotensin-aldosteron RAS vasodilatory diuretic peptides
ivabradine ventricular_ filling heart_ failure hpEF
English-language transfusions iron erythropoiesis-stimulating agents anemia congestive heart_ failure coronary_heart_de transfusion
bNP glomerular filtration_ rate hypertension transmitral E-wave diastolic_ mitral_ annular_ velocity
β-blockade cAMP-dependent protein kinase pKA β-adrenergic receptor_activation
erythropoiesis-stimulation agent_therapy
clinical genetic CHF
black race mortality_hospitalizationhazard ratio cardiovascular_ mortalityHF
percutaneous_des_vessel model chronic_Myocardial_ ischemia stent polytetrafluoroethylene tube bottleneck
Centers_for_ Medicare_ and_ Medicaid Services cMS hospital_quality_de_capitaux_de_capitaux mortality readmission penalties
heart_ failure tumor_ necrosis factorTNf tNF antagonists HF
signal transduction cascade transcription factors cardiomyocytes transcription factors epigenetic changes chromatin structure
cox proportional hazard_modellen temps-dependent covariates follow-up physician
multivariable logistic analysis
annular_ size_reduction surgery diastolic_ mitral_ valve_ tethering anterior leaflet opening papillary_ muscles left ventricular_ dilatation
hypertensive HFPEF sodium-restricted DASH ventricular_ diastolic_fonctionnement arterial_ elastance ventricular-arterial coupling
CHF hCT polymorphisms anthracycline metabolism iron homeostasis anti-oxidant_de_fence myocardial remodelling
implantation_de_lutte_de_conduite_de_conduite_de_lutte_de_conduite_de_capitaux diameter_ stenosis
heart_ failure acute_Myocardial_ infarction
aldactone_ Evaluation_ Study symptomatic chronic_ advanced_heart_ failure aldosterone_ antagonist spironolactone mortality
medication
pathophysiological
lVAD
scientific literature HM_ II HeartWare
creatininehazard ratio dL
implantation implantation implantation implantation implantation
radial_ artery_ tonometry
HR variability_turbulence
low-dose dopamine nesiritide renal dysfunction
risk_de_ death glomerular_ filtration
Medicare breast cancer breast cancer chemotherapy sEER-Medicare Texas_cancer Registry_Medicare
signalosome_ complex scaffold_ protein kinases sequential phosphorylation
magnetically levitated centrifugal-flow_chron LVAS
cardiomyocytes pde2 activity cGMP nitric oxide_ donors pde2 inhibition β-AR responsiveness
ejection_fraction b-type natriuretic_peptide patients_hospitalized heart_ Failure
adrenergic receptor sphingosine_phosphate receptor S1PR cardiac_ hypertrophic response heart_ failure
ECs HDL phosphorylation eNOS-Ser eNOS-Thr PKc-βII-Ser
rCTs sts h hm sts TM
mouse ventricular_Myocytes sarcomere
administrative databases province_de_ Alberta discharged_ alive hospital
PASp
cRT_on_ assignment temps_ to_ death HFhazard LVEF
heart_ failure myocardial_ collagen tissue
l-dKO cardiac IRS1 iRS2 proteins heart_ failure impaired cardiac_energy_ metabolism p38α mitogen-activation protein kinase
nicorandil doxorubicin-induced heart_ failure rats hemodynamic perturbations mitochondrial dysfunction ultrastructural antitumor
Rhythm_control therapy af atrial structure sinus rhythm delayed rhythm_control
RR_de_heart_puissance bisphophonates crude RR
physician adherence guideline_ recommendations heart_ failure Clinical_ PracticeCPg
acute_heart_ failure renal dysfunction low-dose dopamine nesiritide renal fonction diuretic therapy
HF implantation_de_ body_ compositionskinfold_ thickness dual-energy X-ray_ absorptiometry echocardiography blood
Medicare fee-for-service_ beneficiaries Centers_de_ Medicare Medicare Medicaid Services propensity-score
hospitals conditions acute_méocardial infarction pneumonia conditions
enrollment_periods heart_ failure
kccq kccccq New York_ Heart_ Association HFpEF HF ef
aCP restrictive red_ blood_cell_transfusion stratégie
implanted left-to-right interatrial_ shunt haemodynamic
Caloric_restriction Aerobic_ Exercise Peak Oxygen Consumption Quality_of_ Life Older Patients Heart_ Failure Preserved Ejection_fraction
ventricular_assist devices lVADs chronic end-stage_heart_ failure bt transplantation
ventricular_pulmanary_pulmanary_ arterial_ couplingpulmonary_ vascular_ resistance right ventricular_ ejection
carvedilol metoprolol implantable implantable_ cardioverter-de_de_fibrillator_therapy MADit-cRT implantation implantable_de_frésynchronization_ Therapy
glucocorticoids HF
ivabradine_group Ea TAC
HFPSI risk_de_ death medical hospitalization HF clinic_ outpatients HF resources
CHm adjunctive dCM heart_ failure
carvedilol inappropriate therapy metoprololhazard
testosterone
peak VO2 change lean_ body_ mass change_ in thigh muscleintermuscular_ fat ratio
guidelines-Heart_ Failure HF
multivariate cox_model figure PASp
cardiac insulin-resistance mitochondrial oxidative metabolism cardiac hypertrophy energy_ deficit hypertrophy heart
rad rad rem rem2 rad Gem_Kir family_ monomeric_g proteins ventricular action EC coupling cardiac_type_ channel_ activity
annular_ size_reduction surgery diastolic_ mitral_ valve_ tethering anterior leaflet opening papillary_ muscles left ventricularLV
pathophysiology heart_ failure preserved ejection_fraction hFPf myocardial_ extracellular matrix accumulation
breathing_control cardiac arrest pulseless ventricular_ fibrillationPVf implanted cardioverter-de_fibrillator
n-terminal proBNP t-proBNP midregional proANpMR-proANp adiponectin CHF bMI FM
acetylcholinesterase inhibitor_ pyridostigmine sympathovagal balance cardiac_ remodeling HF myocardial infarction
cardiac_ sympathetic activity i-meta-iodobenzylguanidine i-MIBG β-blocker
Swedish Swedish web-system evidence-based_care Heart_ disease Recommended Therapies
LVEF clinical_composite_ response reverse remodeling temps HF
brain_ natriuretic_peptide bNP bNP
pde_ superfamily pde2 cgmp cAMP_hydrolysis negative cross talk cgmp cAMP signaling
TAPselongitudinal RV_ fiber_shortening PASp RV in vivo RV_ length-force
mitochondrial-targeted antioxidant protectionive_peptides Szeto-Schiller SS20 cardiac implant proteomic remodeling pathways
économique_ Analysis Patient_ Management_ Interventions Heart_ Failure Cost-Effectiveness
re-hospitalization admissions
coprimary_ end points cumulative_ urine volume decongestion_ end point serum cystatin c enrollment
cardiac_ arrest cardiopulmonary_ resuscitation cPR posterior_ wall_ infarction cardiac centre
diabetes saxagliptin sitagliptin pioglitazone sulfonylureas long-acting insulin
hyperkalemia mineralocorticoid receptor_ antagonists_ in_heart_ failure
aCP erythropoiesis-stimulation agents
ambulatory patients heart_ failure ejection_fractionrEF renin-angiotensin_system RAS β-blockers
uPR ventricular_synstolic HF implanted pluripotent stem_cell-derived cardiomyocyteshiPSc-CMs
coPD CHF cRF ICC kappa coefficients
implantable implantable implantable cardioverter-defibrillator_de_activation implant
heart_ failure left ventricular_ ejection fraction
heart_ failure myocardial_function children dilated ventricles
cochrane_ Effective_ Practice organisation_of_ Care_ Taxonomy
mouse rad_q65p murine human Rad Q66p l-type_ currents cav1.2 cav1.3 rad
implantable implantable cardioverter-de_de_activation implantable implantable_ cardioverter-de_de_activation implantable_ cardioverter-de_defibrillator_ shocks
mouse_heart_ failure HF hypertensive_heart_ disease hHD pathophysiology hHD therapeutic_ targets hHD
MI hf
national Medicare patients acute_hospital HF AMI pna
ctnt NT-proBNP aRIC HF figure aucs continuous NRIs
Cardiovascular events sST2 status
incubation EC HDL NYHA-IIIb phosphorylation eNOS-Ser phosphorylation eNOS-Thr HDL
HF long-term_ mortality LVEF
sarcoplasmic_ reticularSR ca(2+)-uptake proteins SR ca(2+)-pump phospholamban infarcted hearts metoprolol
global left_ventricular_ longitudinal_ systolic strain gLS left_ventricular_ mechanics adverse cardiovascularCV atrial_ fibrillationAF
early-onset HF HF EF HF HF HF HF MI prevention
carvedilol Willebrand metoprolol β2-adrenergic receptor_haplotype
feasibility implant_de_ exercise intramuscular testosterone_ supplementation
heart_ failure HF plasma b-type_ natriuretic_peptide bNP ejection_fraction HF sex
gLS left ventricular_ ejection_fractionLVEF systolic_ mitral_ annulus_ velocity CV
implanted_monitoring implanted_ implanted_ monitoring devices office hours structured_ telephone support sts human-to-human contact h machine interfaceHM
temps_de_up_go tug chronic_ obstructive_ pulmonary disease coPD chronic_ heart_ failure CHf chronic_ renal_ failureCRf
temps-dependent cox regression figure beta-blockers beta-blockers inappropriate therapy antitachycardia_pacing aTP shock therapy
ethically_ complex situations pediatrics families religious_ beliefs life-sustaining
patient preferences priorities guideline-recommended medications
coût rhythm-control
figure ventricular ejection fraction figure median eGFR ml
CD34_vegFR2_cells functional_capacitation CD34_vegFR2_cells
fit unfit cRF hazard ratios
Medicare_ Patient_ Safety_monitoring_system mpSMS adverse event_ rates acute_Myocardial infarction congestive_ heart_ failure pneumonia conditions surgery
HFPSI blood urea_ nitrogen b-type natriuretic_peptide New York Heart_ Association diabetes atrial_ fibrillation_flutter
cRT
crude 28-day figure-fatality HF
pratiques_level_recommended treatment outpatients heart_ failure reduced ejection_fraction
sampling CHF race_ethnicity cumulative anthracycline exposure stem_cell autologous
tension_fpassive_sarcomere length muscle_ strips kcl-KI treatment titin extracellular matrix Fpassive
aerobic_de_ resistance_training conditions exercise_puissance muscle_strength quality_of_ life cardiac_proBNP inflammatory hsCRp
hospital readmission aCR Potential_ Preventable_ Readmission pPR Centers_de_ Medicare Medicaid cMS
reversibility heart_ failure myocardial infarction m β-adrenoceptor blockade infarcted rats metoprolol

congestive_ heart_ failure
secretion arginine_ vasopressin aVP physiologique_processes CHF inhibition aVP vasopressin_ receptor_ antagonist therapy CHF
implantable_defibrillators circulatory_ support transplantation heart_ failure therapies disease
rats caspase-3 activity phosphocreatine adenine nucleotides cytochrome bcl2 Bax caspase
rapid_ right ventricular_pacing Bax bcl-2 Caspase-3 RTq-PCr interventricular_ septum biopsies beagle dogs heart_ failure
angiotensin_converting enzyme_ inhibitor_angiotensin_ receptor_blockers β-blockers heart_ failure ejection_fraction
sodium-restricted hypertension_dietDASh ventricular_ diastolic_ function arterial_ elastance ventricular-arterial coupling hypertensive hFPEF
acute HF HF ASTRONAUT PRONTO patient enrollment
metoprolol carvedilol sympathetic activity
Hospitalized HF Diseases Clinical_ Modification codes
Rad Q65p gating_ movement wild-type Rad Q65p substitution l-type_ channel_ inhibition RGK
heart_puissance proteomics changes actin_cytoskeleton_pathways mitochondrial metabolic pathways
echocardiograms left ventricular base midpapillary IVc occlusion biVP STE twist basal rotations RS synchrony
pyridostigmine coronary artery_ ligation cardiac vagal sympathetic tone cardiac remodeling ventricular dysfunction HF
implants New York_ Heart_association NYHA class_ II Heart_ Failure eplerenone placebo standard_ Heart_ Failure_ Medicines
discharge
life_ expectancy heart_puissance
heart_ failure_discharges University_of_connecticut_ Health Center
Pulmonary_caillary_wedge_tension hg hg figure right_ atrial_tension pulmonary_tension pulmonary_tension pulmonary resistance
acute_heart_ failureHF pharmacologic studies calcium-sensitizing agents endothelin vasopressin adenosine
aortic_insufficiency mechanical_ circulatory_ support continuous_ flow left ventricular_assist devices pulsatile devices
HF HF HF phenylephrine haemodynamic stress surgical transverse_aortic_constrictionTAC jq1 cardiac hypertrophy
RAas direct_renin inhibitors neutral endopeptidase_ inhibitors vasopeptidase inhibitors angiotensin receptor_blockers
pde2_overexpression healthy cardiomyocytes cAMP cAMP ca2 inotropic effect acute β-AR_stimulation basal_contractility
bottleneck_ stent implanted proximal_ left_ anterior descending LAD proximal_ circumflex artery LCx LAD
acute_Myocardial_ infarction AMI incidence heart_ failure HF complicating AMI
i-MIBG cardiac_ washout carvedilol metoprolol treatment β2-adrenergic receptor
Muscle_ aerobic_ capacity postexercise phosphocreatine_resynthesis Fontan
Cardiac_resynchronization_therapy cRT dialysis-dependent patients heart_ failure HF
efficacy eplerenone hyperkalemia renal fonction EMPHASIS-HF epleren_in_ Mild Patients Hospitalization SurvIval Heart_ Failure
h-dKO ventricular mass cardiac_ apoptosis fibrosis
inappropriate ATP inappropriate shock therapy
cardiorespiratory_ fitness crf body_ mass index heart_ failure HF mortality cardiovascular_risk
hospitalized hHF dipeptidyl_ peptidase-4 dPP-4 antihyperglycemic agents
quality_ improvement database multivariable Cox modeling Heart_ Failure_ Patient_ Severity_ Index hPSI University_ Michigan HF
cardiac patients acute_méocardial infarction AMI congestive heart_ failureCHf left ventricularLV
neonatal rat ventricular cardiomyocytes chronic insulin exposure IRS1 iRS2 proteins insulin action
echocardiograms left ventricular_ midpapillary atrioventricular_delay avd interventricular_delay vd STE circumférential strain radial strainRS
New York_ Heart_ Association_NYHA HF ejection fractions chronic_directed_ medical therapyGDMT
LBBB QRs
pka regulatory rIIα catalytic cα phosphorylation HF
abnormal ca(2+) handling dyssynchronous HF myofiber_ shortening_puissance septum depresses myofiber_ shortening_puissance
CHF c-Kit_cells transforming growth_factor-β tGF-β epithelial mesenchymal transition pluripotency shams
label-free shotgun_proteomics global_proteomics transverse_ aortic_constriction TAC heart
hff ventricular_ ejection fraction hfpEF left ventricular_ ejection fraction RAS- β-blocker index HF
activation PKc-βII HDL NYHA-IIIb malondialdehyde
g-protein-coupled receptors
figure
NT-proBNP inflammatory_ biomarkers hsCRp IL
ejection_fraction frail biological_ phenotype risk_de_ death
resting_HR
TGF-β inhibition c-Kit_cell_ phenotype cardiac_progenitor_ function cell_ expansion
BETs neurohormonally_ induced_heart disease jq1 phenylephrine-mediated hypertrophy cardiomyocytes pathological gene induction
concentric_ remodelingCR concentric_ hypertrophyCH left ventricularLV heart_ failure hpEF eccentric hypertrophyEH
BAT implantal_pro-brain_ natriuretic_peptide burden_de_heart_ failure GDMT-treated NYHA
MLHF MLHF
nonpace_non-DNx sham-Innervated inv nonpace DNx pace_non-DNx chf-inv pace_ DNx chf-DNx
PSSS btes btes
hemoglobin hgb HRQoL training-induced changes HRQoL patients Heart_ Failure HF-ACTION
Risk RV_ dysfunctionhazard_de_fonctionnement c cachexia
atrial_fbrillation_congestive_ Heart_ Failure expenditures patients rhythm rate-control
calcineurin_nfat figure miR-25 expression helix-loop-helix bHLh transcription_ factor Hand diseased human mouse_méocardium
heart_ failure myocardial_ischaemia tachy- bradyarrhythmias valvular_ regurgitation pulmonary embolism renal dysfunction
hABC HF HF HF HF hz SD
NT-proBNP figure
prognostic_power r-r interval_ oscillations HR_ variability short-term_fractal_ scaling
heart_ failure HF ventricular_tachycardia HF HF VT hnorm
gLS cox model chronic_ heart_ failure hypertension diabetes glomerular_ filtration_ rate LVEF adverse CV
diastolic filling_ formalism relaxationviscoelastic passive_stiffness doppler_ mitral inflow_ velocity e-wave
VAD ventricular_assist_ device_ support ECmo extracorporeal_ membrane_ oxygenation_ membrane VAD
mt NYHA HFpEF hFrEF HFpEF HFpEF
coût-effectiveness heart_ failure_de_conduite
humanized mouse_lacking murine_ resistin human Retn gene hum-retn_mice inflammation-stimulated resistin
angiotensin_converting_ enzyme_ inhibitor_angiotensin_ receptors_blockers β-blockers
tt mena_mice cardiac injury ejection_fraction fraction heart_dilatation hypertrophy transverse_aortic_constrictionTAC
heart_ failure implantation cfa SCHf Self-Care_ Maintenance Self-Care Management Self-Care_ Confidence
resynchronization-Defibrillation Ambulatory Heart Failure Trial implantable cardioverter_de_fibrillator-CRT
ischemic events is ischemic_ cardiomyopathyIC cardiac_ resynchronization therapy defibrillator cRT-d efficacy
renal dysfunction chronic_ obstructive pulmonary disease diabetes peripheral_ vascular disease left ventricular ejection_fraction ICD shocks ischemic_ cardiomyopathy male sex
CHF CHF SD testosterone
Raf-MEK-erk_ scaffold_ proteins adaptive maladaptive cardiac remodelling therapeutic
functional MS LV_dilatation heart_ failure HF LV functional MS HF MR degenerative_ mitral valve
angiotensin converting_ enzyme_ inhibitor angiotensin-receptor_blockers β-blockers heart_ failure
associations New York_ Heart_association kccq kccq symptom_ domains Spearman correlations HF
LV ejection_fraction LV strain_de_strain_ rate_ at_synstole diastolic indices LV strain_ rate diastole_con early_ transmitral_ flow sinus rhythm
c57b figure ANG_ II infusion infusion uninephrectomy ANG_ II infusion salt_ loading infusion uninephrectomy salt_ loading
early_transral_ blood_ flow_fréquence_ over_ tissue doppler_ early_ diastolic_ mitral_ annulus_ velocity pulmonary_ capillary_wedge_tensionPCWP decompensated_ systolic_heart_ failureHF
peak VO2
AMI hospital
kccq figure HFpEF
ctnt NT-probNP HF
c-terminally circulating NT-proBNP physiological_ proteolysis leu3-Gly
HFpEF patients New York Heart_ Association figure ejection_fraction
depressed left_ventricularLV_depressed_depressed_ left_ventricular_LV_ systolic_tension pressure ejection_fraction fraction_ shortening cardiac_puissance LV end-diastolic_tension metoprolol
baroreflex_ Activation Therapy Heart_ Failure Reduced_ Ejection_ Fraction
enrollment
HF HF HF HF HF HF HF raised_ blood glucose levels obesity tobacco aging systemic hypertensionSH rheumatic fever Chagas_ disease
age-adjusted risk HF
cf figure
eGFR eGFR figure uncontrolled hypertension diuretics temps
myocardial_phosphodiesterase-2 pde2 heart_ failure HF pde2-mediated beta-adrenergic receptorβ-AR cardiomyocytes
heart_ failure cardiac_ resynchronization therapy implantable cardioverter-defibrillator device carvedilol inappropriate ATP therapy metoprolol
epicatechin-rich cocoa Skm mitochondrial structure Ramirez-Sanchez ciaraldi Perkins Murphy naviaux Hogan ceballos Maisel Henry
risk_de_ death urgent_ readmission
Mena_overexpression TTA tgtet_Mena_mice TAC
PD diuretic_refractory_ severe-end-stage HF
ATP aac mitochondrial oxidation glucose lactate fatty acids myocardial_ glycolysis
proangiogenic effects b activation VEGF_pathway adenoviral_vector decoy VEGF_ receptor ad-flk adenovirus ad-c
eplerenone potassium potassium hyperkalemia medication
implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation proximal LAD implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation proximal LAD LCx implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation proximal LAD implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation
aged New York Heart_ Association_ class_ III heart_ failure HF left ventricular_ ejection pp
potassium spironolactone AAs race_ by_réquence
cPET CHF
echocardiography LV end-diastolic volume MR mitral valve mVA pressure
post-LVAD AI aortic valve_ oversewing leaflet repair bioprosthetic aortic_ valve_ replacement
veterans VA health_cares systolic_ heart_ failure β-blocker angiotensin converting enzyme_ inhibitor angiotensin-receptor_blocker
exercise-induced pulmonary_ artery_ systolic_tensionPASp stress doppler echocardiography right ventricular_contractile_ reserve pulmonary_ hypertension right_heart_ failure
MEDLINE EMBAse HEalthSTAR cINAHL cochrane Library Campbell Joanna Briggs Institute Evidence_ Based Practice
heart_ failure neuro-hormonal_system angiotensin converting enzyme_ inhibitors angiotensin_ converting_ enzyme_ inhibiteurs_ intolerance mineralocorticoid receptor
open chest model twist RS RS synchrony CS STE co
TAPse-to-PASp ratioTAPSe_passp cox_ regression Kaplan-meier
older obese hfff
Human heart_ failure mRNA mRNA voltage-gated_ cardiac_na+ channel_subunit sCN5a truncated_nonfunctional channels endoplasmic reticulum
paediatric heart_ failure myocarditis dilated cardiomyopathy heart_ failure anthracycline childhood malignant disease
économique_ Analysis Patient_ Management_ Interventions Heart_ Failure Cost-Effectiveness_ Model
natriuretic_peptidesNPs b-type NP n-terminal_pro-B-type NP acute_heart_ failure Emergency_de_ED acute_ dyspnea
peak VO2 vco2 slope exercise oscillatory ventilation eOV pressure end-tidal_co2PETco2 cardiopulmonary
Denmark bisphosphonates raloxifene
longitudinal strain_de_ left_ventricle echocardiographic measurements patients baseline echocardiography cRT echocardiograms
hypertension LV_dilatation LV dysfunction MR MS
HDL_healthy CHF-NYHA-IIIHDL NYHA-II CHF-NYHA-II
platelet-activating factorPAf metabolic enzymes
acute_care_ surgery ocs oHT transplantation medical therapy intravenous inotropes ventricular_assist devicesVADs
renin-angiotensin-aldosterone_systemraas hff angiotensin-converting enzyme inhibitors angiotensin_converting_ enzyme_ inhibitors aldosterone_blockade HFpEF
HFpf ivabradine ventricular_ filling_puissance ventricular_puissance_responsive exercise
admission lVET unfavorable outcome
heart rate_ blood_tension renale spironolactone RAS_blockers
cardiac_ performance β-adrenoceptor_blockade heart_ failure SR_ca(2+)-pump reverse cardiac remodeling plasma catecholamines
congestive_ heart_ failure mitochondrial_ damage TAC mitochondrial_ proteome
HF-ACtion HF HF ventricular_ ejection_fractions HRQoL Kansas City Cardiomyopathy kccq
tolvaptan hyponatremia Japan congestive_ heart_ failure diuretic_therapy serum_sodium_ levels systolic_ function
depressed myofibrillar ca(2+)-stimulated ATPase activity mRNA mRNA mRNA phospholamban α-myosin_ heavy chain mRNA mRNA
inesthetized dogs coronary_microembolization-induced HF ventricular_ end-diastolic_tension myocardial_ oxygen ejection ventricular_power
baseline heart_puissance figure administration_de_ contrast agent ms
mDC mDC mdd figure
HF idiopathic dilated_ cardiomyopathy c'd ischemic SH valvular alcohol
ST2 functional capacity ambulatory patients HF Heart_ Failure figure Exercise_ Training HF-ACTION HF
implantable_carvedilol implantable_ cardioverter-de_fibrillator therapy MADit-cRT multicenter_automatic_deibrillator implantation Cardiac_resynchronization Therapy
angiotensin-converting enzyme_ inhibitorsangiotensin_ receptor_blockers β-blockers therapy
ischemic HF_pathogenesis NYHA_ functional_ class_ IV glomerular filtration_ rate heart hypertension diabetes mellitus myocardial infarction
cRT resynchronization_reVErses resynchronization_reverses Systolic_ left_ v_entricular_ dysfunction
action β1ARs s1PR1s myocyte cAMP receptors g-protein-coupled_ receptor_ kinase
PAf-cPT PAf figure lyso-PAf-AT PAf-AH lp-PLA2
angle aUC
Rate-control patients cardioversions coût antiarrhythmic drugs
implantation spironolactone
diabetes_ mellitus cardiomyopathy β-blocker angiotensin-converting enzyme_ inhibitor angiotensin_ II receptor_blocker
epleren_Post_myocardial_ infarction_ Heart_ failure SUrvival Study eheSUS post-myocardial_ infarction heart_ failure mortality aldosterone antagonist epleren
cardiopulmonary_ exercise_ rehabilitation patients_chron_ heart_ failureCHf CardioPulmonary_ Exercise_ Testing cPET exercise_ rehabilitation
risk_reduction heart_related_ mortality sudden death
DASh_sRD 24-hour brachial_synstolic pressure central_en-systolic_tension hg
all-cause_ mortality HF LVEF
HF obese body_ index black ethnicity idiopathic-dilated_ cardiomyopathy
ventricular_ ejection_fraction World_ Health Organization idiopathic_ dilated_ cardiomyopathy negative coronary angiography
European Society_of_ Cardiology hfff hfff heart_ failure LV ejection_fraction non-dilated left ventricle diastolic_ dysfunction inimpaired LV_ relaxation LV diasto_ stiffness LV filling_tensions
glomerular filtration_ rate eGFR diabetes cholesterol CLCNKA GG genotype
echocardiography LV end-_diastolic_dimension LV end-_diastolique_tension_wall_ stress lung_weight ACF
heart_ failure ejection_fraction standard_ cardiac_ rehabilitation_care Nordic_ walking
dRS-stratified hazard ratios sitagliptin pioglitazone sitagliptin sulfonylureas insulin
skeletal_ muscle_ mass t-score figure
RAS- β-blocker_uptitrations end-point_de_ all-cause_ mortality hff hf figure
testosterone oxygen_uptake Beck_depression inventory leg_ strength Medical
implantation Heart_ Failure HF-action social_ support barriers_ to_ exercise
ST2 cardiovascular_ death HF hospitalisationhazard_ ratio all-cause_ mortality
New York_ Heart_ Association cardiopulmonary_ exercise lean_ mass_ quantification dual x-ray_ absorptiometry calf_ muscle magnetic_ resonance_ spectroscopy
placebo dopamine low-dose nesiritide diuretic therapy renal
cRT ventricular_ ejection QRs echocardiographic_de_ left_ventricular_synchrony
left ventricular ventricular HF HF transthoracic echocardiography transmitral_ flow_ velocities mitral annulus velocities diastole
acute_ coronary syndromes
HF lyso-PAf-AT PAf-cPT PAf-AH lp-PLA2
medical therapy sternotomy aortic_ valve bioprosthetic valve_ replacement dacron patch_closure aortic_ valve_ repairs transcatheter aortic_ valve_ replacement
plasma_n-terminal_pro-B-type_ natriuretic_peptideNT-proBNP survival patients acute_ heart_ failure
cardiac_ troponin t ctnt biomarkers incident HF HF Atherosclerosis Risk_ in_ CommunitiesARIc
figure
figure
reverse_ remodeling ejection_fraction mortality HF dialysis
EH LVf figure ratio_de_synstolic_ blood_tension end-systolic_ volume hg ml
echocardiography ml ml ml ml ml ml ml ml ml ml ml ml ml ml ml ml ml ml ml ml ml ml ml ml ml ml ml ml ml ml ml ml ml ml ml ml ml ml ml ml ml mlva mean_tension_ gradient hg
double-blind placebo-controlled clinical trial renal Optimization stratégiesROSe hospitalized patients acute_ heart_ failure renal dysfunction glomerular filtration
BETs chromatin-mediated signal transduction Pol II co-activation transcription_ factor HF nucléaire_factor_de_activation_ T cells nucléaire_fbNF-κb transcription_ factor
mortality hospitalization exercise tolerance cardiovascular events myocardial infarction congestive heart_ failure arrhythmia cardiac death hypertension venous_thromboembolic cerebrovascular events
EO-cFUs diabetes EO-cFU figure
all-cause cardiovascular mortality
immunoblotting radioenzymatic- fluorescence_ resonance_énergie_ transfer-based assays video edge detection epifluorescence_ microscopy l-type_ca2 myocardial_ tissues cardiomyocytes HF
Exercise_puissance peak_ oxygen_ consumptionvo2 ml_kg/min QOL Minnesota_ Living_ with_ Heart_ Failure mHF
eAST atrial_ fibrillation_for_ Stroke_ prevention_trial
patients HF ventricular_ ejection_fraction hospital acute_ outpatient_settings
TAC-induced proteomic alterations mitochondrial-targeted_peptide_ SS31 perturbed mitochondrial_fonctionnement pathway_ alterations TAC mitochondrial-targeted_peptide_ drugs heart_ failure
HF hf ventricularLV ejection fraction hpf echo-Doppler studies pro-brain-type_ natriuretic_peptide
low-volume EDs
hABC hbc hz hz hf hf hf hf hf hf hf discrimination c-index figurenet-reclassification-improvement
cardiac transplant ECCT diabetes mellitus chronic_ kidney_ disease glomerular filtration
cf msea Self-Care_ Maintenance_ Scale cf msea Self-Care_management_ Scale msea Self-Care_ Confidence scale
BAT distance_ walked figure quality-of-life
preoperative hypoalbuminemia postoperative_ normalization albumin levels
implantation acute_méocardial_ infarction AMI
heart_ failure ischemic_nonischemic cardiomyopathies implantable implantable cardioverter_defibrillators cardiac resynchronization_therapy cardiac transplantation ventricular assist devices
SAF PF PF figure central_venous_tension hg hg sVR figure cardiac index
admission_median bNP figure EF
heart_puissance_admission heart implantationLV_assist device death
ejection_fraction vitesse_de_ circumferential_ shortening systolic elastance contractile_ efficiency ACF allopurinol rats o2 consumption_ rate cardiomyocytes extracellular flux
HFpEF LV_geometry LV_ hypertrophy LVh wall_ thickness CR LVh RWT
angiotensin_ receptor_ neprilysin_ inhibitor_prodrug angiotensin_ receptor_ antagonist_ valsartan hypertension
blood pressure mitral valve plasty degenerative MR p3 chordal ruptures triangular resection edge-to-edge anastomosis ring_ annuloplasty Physio Ring
shuttle_walk_test oxygen_uptake muscular_ strength echocardiographic measures N-terminal pro-brain_ natriuretic_peptide inflammatory markers depression beck_depression_inventory health-related_quality_of_ life minnesota Heart_ Failure Medical Outcomes
interaction_terme LVEF long-term_ mortality
grestar-Kyoto lean ZSF obese ZSF1 high-fat diet metabolic renal echocardiographic evaluations euthanization
Kaplan-Meier curves log-rank
multivariate cox_ regression AF_type long-standing_ persistent AF hypertension maintenance sinus rhythmhazard ratio
chronic HF-ref NYHA_ functional class_ II eGFR potassium eplerenone
ffffff double_energy_ X-ray_ absorptiometry dXA non-diabetic patients chronic_ heart_ failure CCcachectic CHF myocardial infarction-both
drug dose spironolactone end point_de_ death hospitalization HF AAs
pulmonary_ arterial_ hypertension inoperable chronic thromboembolic pulmonary_ hypertension impaired right ventricular_puissance implanted pulmonary_ arterial_ hypertension medication stress echocardiography cardiopulmonary_ exercise
cardiovascular_ death btes btes cardiovascular_ death HF
index_de_fréquence_de_fréquence_de_la_fréquence_de_fréquence_de_puissance_de_cause_ readmission
implantable implantable_ cardioverter-de_de_activation implantation implantable_ cardioverter-de_de_activation
Cardiac_ magnetic_ resonance left_ atrial_ area pulmonary_ vascular_ resistance
HF ventricular_éjection fraction HF New York Heart_ Association echocardiographic cardiopulmonary_ exercise
abd classification American College_of_ Cardiology acc association AHA New York_ Heart_association NYHA structural_ heart_ disease
mva continuity equationLV end-diastolic volume LV end-systolic volume mitral_ filling_ flow mva velocity_ time mitral_ filling_ flow continuous_ wave doppler_ echocardiography MR mitral valve plasty
statitistical_ significance RM sts_h h h h h h office_ hours h h h h h h
HFPSI Ann Arbor Veterans_ Affairs HF clinicVA-RT cohort VA_RT HFPSI HFPSI
AAs spironolactone dose hyperkalemia potassium
risk_de_long-term_ mortality LVEFhazard ratio
HFpEF HFpf hpf hpf hpf hpf hpf hpf hpf hpf NYha_ class_ III distance_ covered mt mt
echo-derived pulmonary_ arterial_tensionPASp right ventricular RV_ annular_ plane_synstolic excursion diastole end-systole
severe CAD electrocardiographic Q waves left bundle_ branch_ block nondiabetes dyslipidemia hypertension tobacco
receiver_ operating_ characteristic_curve ue ratios PCWP
trastuzumab-treated patients coronary artery disease hypertension
LVEF clinical composite response cRT_on cRT_ OFF LV_ end_ systolic volume_ index
TGF-β signaling TGF-β receptor smad small-molecule inhibitors c-Kit_cell yield epithelial mesenchymal transition markers pluripotency_ marker c-Kit_cell differentiation cardiomyocyte-like cells
hFrf diuretics co-morbidities mwt NYHA
HF implantation echocardiography LV end-diastolic volume_ index LV ejection MR mitral valve_ opening mva mean_tension hg
implantation ivabradine SHIFT Systolic_ Heart_ Failure inhibitor ivabradine_trial ivabradine echocardiographic
h h hg hg hz hz hz hz hz hz
Chronic_ Kidney Disease Epidemiology figure glomerular_ filtration_ rate eGFR
paraDIGm-HF stabilized chronic_heart_ failure systolic_ dysfunctionLV functional class NYHA_ II-III bNP bNP cardiovascular_ death hospitalization_ for_heart_ failure ARNI sacubiltril valsartan
hyperkalemia African Americans AAs
reverse remodeling pre-CRT LV ventricular angle_de_ventricular ventricular angle_de_ventricular ventricular
b-type_ natriuretic_peptide b-type_n-terminal_pro-B-type_ natriuretic_peptide Diagnostique coronary_ artery_ disease b-type_ natriuretic_peptide bNP ventricular_ cardiomyocytes ventricular_ wall_ stress myocardial ischemia
iRS2 hyperinsulinemia myocardial_ insulin_ resistance cellular_ dysfunction iRS2 heart-specific IRS2 double-knockout h-dKO liver-specific IRS
angiotensin-converting enzyme inhibitors_angiotensin_ receptor_blockers interquartile
ivabradine
liberal transfusion protocols
risk_de_ death unplanned_ readmission
hEK embryonic_ kidney β1AR downregulation sphingosine_-1-phosphate S1PR1 agonist isoproterenol β-adrenergic_ receptor_ agonist
Kansas City Cardiomyopathy Minnesota Heart_ Failure depressive_ symptoms beck_depression inventory depression natriuretic peptide endothelial_frélatation ventricular_ diastolic
cardiovascular events atrial_ fibrillation left ventricular ejection_fraction diabetes mellitus peripheral_ vascular disease myocardial infarction heart_ failure
conjunction diastolic function ventricular-arterial coupling
disease_risk score dRS sitagliptin saxagliptin pioglitazone saxagliptin sulfonylureas
revascularization coronary artery_ bypass surgery hazard ratio percutaneous coronary intervention systolic blood_tension left bundle_ branch_ block baseline_ electrocardiogram
biomedical treatment CHm ventricular_éjection fraction left ventricular_ diastolic_ end
heart_ failure ventricular_ ejection fraction β2-receptor carvedilol metoprolol
low-volume ED
health_budy_program risk-adjusted all-cause_ mortalityhazard ratio figure
multivariable-adjusted hazard ratios Mediterranean_diet_ score
ctnt NT-probNP aRIC_f hf systolic blood_tension antihypertensive medication smoking coronary_ heart_de_fréquence HF receiver_ operating_ characteristic_curve discrimination nRI
efficacy eplerenone hyperkalemia renal_ function EMPHASIS-HF heart_organisée NYHA glomerular filtration_ rate eGFR serum_potassium
low-dose_ nesiritide 72-hour cumulative_ urine_ volumenesiritide figure cystatin_c
Nordic_ walking_de_fonctionnel_puissance m m m mt physical activity
hyperkalemia WRF diabetes eGFR systolic_ blood_tension hg
PAf biosynthetic enzymeslyso-paf acetyltransferaselyso-paf-AT dithiothreitol dt CDp choline alkyl-2-acetyl-sn-glycerol choline_phosphotransferase pf-cPT catabolic isoenzymesPAf-acetylhydrolase lipoprotein-associated phospholipase
ivabradine_group baseline_ follow-up_ exercise_puissance METs peak_ oxygen_uptake
CHF ht ht ht ht hypertension NAD_h-oxidase_subunit RAC2 doxorubicin_efflux_ transporter
NYHA classification class_ II class_ III figure Duke_ Activity_ Status_ Index Kansas_City_ Cardiomyopathy
low-dose dopamine 72-hour cumulative urine_ volumedopamine
figure hard ratio hz figure figure baseline_ glomerular filtration_ rate hz figure chronic_ obstructive_ pulmonary disease diabetes ventricular_ ejection fraction
peak_ oxygen_uptake hazard ratio figure ventilatory_ efficiency slope hemoglobin left ventricular_ ejection_fraction renal
Kansas City_cariomyopathy figure Minnesota_ Living_ Heart_ Failure questionnaire Beck_depression inventory zung flow-mediated_dilatation_ diameter Fes placebo b-type_ natriure_peptide
